{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:32:26Z","timestamp":1792103546269,"version":"4.4.0"},"reference-count":304,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Conference on Undergraduate Innovation and Entrepreneurship","award":["X2026102260086"],"award-info":[{"award-number":["X2026102260086"]}]},{"name":"National Conference on Undergraduate Innovation and Entrepreneurship","award":["X2026102260088"],"award-info":[{"award-number":["X2026102260088"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular disease progression is shaped by a close interaction between metabolic adaptation and inflammatory signaling. In injured cardiac and vascular tissues, ischemia, pressure overload, lipid stress and metabolic excess reshape how cardiomyocytes, endothelial cells, immune cells and fibroblasts sense damage and communicate with their microenvironment. Cardiovascular inflammation follows a staged tissue response, from danger-signal sensing and nuclear factor-\u03baB-related priming to inflammasome activation, cytokine amplification, leukocyte recruitment, efferocytosis and chronic remodeling. Metabolic reprogramming shapes this sequence by altering substrate use, redox control, biosynthetic routing and metabolite signaling. A major challenge is that glycolysis, fatty acid oxidation and amino-acid metabolism do not carry fixed biological meanings; their effects depend on the cell type, measurement layer and disease phase in which they occur. This review examines metabolism\u2013inflammation crosstalk in cardiovascular disease by linking core inflammatory pathways with metabolic sensors, immune-cell metabolic reprogramming and signaling metabolites, then comparing disease-specific mechanisms in myocardial infarction\/ischemia\u2013reperfusion injury, heart failure, atherosclerosis, hypertrophic remodeling and myocardial fibrosis. We emphasize how apparently similar metabolic shifts can represent adaptive repair, inflammatory amplification or maladaptive remodeling in different compartments. The therapeutic discussion separates pathway activity from targetability and uses anti-inflammatory trials and metabolic interventions to define when patient selection, pathway engagement and safety considerations support targeted treatment.<\/jats:p>","DOI":"10.1186\/s43556-026-00599-x","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:04:42Z","timestamp":1790237082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Roles of inflammation and metabolic dysfunction in cardiovascular diseases: molecular mechanisms and therapeutic targets"],"prefix":"10.1186","volume":"7","author":[{"given":"Yue","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0915-1932","authenticated-orcid":false,"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"4","key":"599_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cvr\/cvx017","volume":"113","author":"J Ritterhoff","year":"2017","unstructured":"Ritterhoff J, Tian R. Metabolism in cardiomyopathy: every substrate matters. Cardiovasc Res. 2017;113(4):411\u201321. https:\/\/doi.org\/10.1093\/cvr\/cvx017.","journal-title":"Cardiovasc Res"},{"issue":"10","key":"599_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/circresaha.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac Energy Metabolism in Heart Failure. Circ Res. 2021;128(10):1487\u2013513. https:\/\/doi.org\/10.1161\/circresaha.121.318241.","journal-title":"Circ Res"},{"issue":"1","key":"599_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","volume":"213","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213(1):15\u201323. https:\/\/doi.org\/10.1084\/jem.20151570.","journal-title":"J Exp Med"},{"issue":"3","key":"599_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tem.2023.10.011","volume":"35","author":"BJ Kopecky","year":"2024","unstructured":"Kopecky BJ, Lavine KJ. Cardiac macrophage metabolism in health and disease. Trends Endocrinol Metab. 2024;35(3):249\u201362. https:\/\/doi.org\/10.1016\/j.tem.2023.10.011.","journal-title":"Trends Endocrinol Metab"},{"key":"599_CR5","doi-asserted-by":"publisher","unstructured":"Henein MY, Vancheri S, Longo G, Vancheri F. The Role of Inflammation in Cardiovascular Disease. Int J Mol Sci. 2022;23(21). https:\/\/doi.org\/10.3390\/ijms232112906.","DOI":"10.3390\/ijms232112906"},{"key":"599_CR6","doi-asserted-by":"publisher","unstructured":"Alfaddagh A, Martin SS, Leucker TM, Michos ED, Blaha MJ, Lowenstein CJ, et al. Inflammation and cardiovascular disease: From mechanisms to therapeutics. Am J Prev Cardiol. 2020;4. https:\/\/doi.org\/10.1016\/j.ajpc.2020.100130.","DOI":"10.1016\/j.ajpc.2020.100130"},{"issue":"9","key":"599_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/circresaha.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res. 2020;126(9):1260\u201380. https:\/\/doi.org\/10.1161\/circresaha.120.315937.","journal-title":"Circ Res"},{"key":"599_CR8","doi-asserted-by":"publisher","unstructured":"Gencer S, Evans BR, van der Vorst EPC, D\u00f6ring Y, Weber C. Inflammatory Chemokines in Atherosclerosis. Cells. 2021;10(2). https:\/\/doi.org\/10.3390\/cells10020226.","DOI":"10.3390\/cells10020226"},{"key":"599_CR9","doi-asserted-by":"publisher","unstructured":"Zhang J, Nie C, Zhang Y, Yang L, Du X, Liu L, et al. Analysis of mechanism, therapeutic strategies, and potential natural compounds against atherosclerosis by targeting iron overload-induced oxidative stress. Biomed Pharmacother. 2024;177. https:\/\/doi.org\/10.1016\/j.biopha.2024.117112.","DOI":"10.1016\/j.biopha.2024.117112"},{"key":"599_CR10","doi-asserted-by":"publisher","unstructured":"Beltran C, Pardo R, Bou-Teen D, Ruiz-Meana M, Villena JA, Ferreira-Gonz\u00e1lez I, et al. Enhancing Glycolysis Protects against Ischemia-Reperfusion Injury by Reducing ROS Production. Metabolites. 2020;10(4). https:\/\/doi.org\/10.3390\/metabo10040132.","DOI":"10.3390\/metabo10040132"},{"key":"599_CR11","doi-asserted-by":"publisher","unstructured":"Yu W, Kong Q, Jiang S, Li Y, Wang Z, Mao Q, et al. HSPA12A maintains aerobic glycolytic homeostasis and Histone3 lactylation in cardiomyocytes to attenuate myocardial ischemia\/reperfusion injury. JCI Insight. 2024;9(7). https:\/\/doi.org\/10.1172\/jci.insight.169125.","DOI":"10.1172\/jci.insight.169125"},{"issue":"11","key":"599_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/circulationaha.119.041882","volume":"141","author":"Y Hadas","year":"2020","unstructured":"Hadas Y, Vincek AS, Youssef E, \u017bak MM, Chepurko E, Sultana N, et al. Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction. Circulation. 2020;141(11):916\u201330. https:\/\/doi.org\/10.1161\/circulationaha.119.041882.","journal-title":"Circulation"},{"key":"599_CR13","doi-asserted-by":"publisher","unstructured":"Poels K, Schnitzler JG, Waissi F, Levels JHM, Stroes ESG, Daemen MJAP, et al. Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability. Front Cell Dev Biol. 2020;8. https:\/\/doi.org\/10.3389\/fcell.2020.581641.","DOI":"10.3389\/fcell.2020.581641"},{"key":"599_CR14","doi-asserted-by":"publisher","unstructured":"Nollet EE, Schuldt M, Sequeira V, Binek A, Pham TV, Schoonvelde SAC, et al. Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy. Circ Genom Precis Med. 2024;17(3). https:\/\/doi.org\/10.1161\/circgen.123.004369.","DOI":"10.1161\/circgen.123.004369"},{"issue":"21","key":"599_CR15","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/circulationaha.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao M, Vander Roest AS, et al. Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy. Circulation. 2021;144(21):1714\u201331. https:\/\/doi.org\/10.1161\/circulationaha.121.053575.","journal-title":"Circulation"},{"key":"599_CR16","doi-asserted-by":"publisher","unstructured":"Previs MJ, O\u2019Leary TS, Morley MP, Palmer BM, LeWinter M, Yob JM, et al. Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy. Circ Heart Fail. 2022;15(6). https:\/\/doi.org\/10.1161\/circheartfailure.121.009521.","DOI":"10.1161\/circheartfailure.121.009521"},{"key":"599_CR17","doi-asserted-by":"publisher","unstructured":"Liu X, Yin K, Chen L, Chen W, Li W, Zhang T, et al. Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics. Cell Discov. 2023;9(1). https:\/\/doi.org\/10.1038\/s41421-022-00490-3.","DOI":"10.1038\/s41421-022-00490-3"},{"issue":"10","key":"599_CR18","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/jci94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, et al. Fibroblast-specific TGF-\u03b2\u2013Smad2\/3 signaling underlies cardiac fibrosis. J Clin Invest. 2017;127(10):3770\u201383. https:\/\/doi.org\/10.1172\/jci94753.","journal-title":"J Clin Invest"},{"issue":"6","key":"599_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00109-023-02323-6","volume":"101","author":"F Wang","year":"2023","unstructured":"Wang F, Yin X, Fan Y-M, Zhang X, Ma C, Jia K, et al. Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction. J Mol Med. 2023;101(6):743\u201356. https:\/\/doi.org\/10.1007\/s00109-023-02323-6.","journal-title":"J Mol Med"},{"key":"599_CR20","doi-asserted-by":"publisher","unstructured":"Karlstaedt A. Stable Isotopes for Tracing Cardiac Metabolism in Diseases. Front Cardiovasc Med. 2021;8. https:\/\/doi.org\/10.3389\/fcvm.2021.734364.","DOI":"10.3389\/fcvm.2021.734364"},{"issue":"12","key":"599_CR21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1161\/circresaha.124.323672","volume":"134","author":"JA Palmer","year":"2024","unstructured":"Palmer JA, Rosenthal N, Teichmann SA, Litvinukova M. Revisiting Cardiac Biology in the Era of Single Cell and Spatial Omics. Circ Res. 2024;134(12):1681\u2013702. https:\/\/doi.org\/10.1161\/circresaha.124.323672.","journal-title":"Circ Res"},{"key":"599_CR22","doi-asserted-by":"publisher","unstructured":"Ong S-B, Hern\u00e1ndez-Res\u00e9ndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek X-Y, Cabrera-Fuentes HA, et al. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:73\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.001.","DOI":"10.1016\/j.pharmthera.2018.01.001"},{"issue":"1","key":"599_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction. Circ Res. 2016;119(1):91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577.","journal-title":"Circ Res"},{"key":"599_CR24","doi-asserted-by":"publisher","unstructured":"Silvis MJM, Kaffka genaamd Dengler SE, Odille CA, Mishra M, van der Kaaij NP, Doevendans PA, et al. Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.599511.","DOI":"10.3389\/fimmu.2020.599511"},{"key":"599_CR25","doi-asserted-by":"publisher","unstructured":"Antonello J, Roy P. Damage-associated molecular patterns (DAMPs) in vascular diseases. J Biol Chem. 2025;301(6). https:\/\/doi.org\/10.1016\/j.jbc.2025.110241.","DOI":"10.1016\/j.jbc.2025.110241"},{"issue":"5","key":"599_CR26","doi-asserted-by":"publisher","first-page":"e2234","DOI":"10.1038\/cddis.2016.140","volume":"7","author":"Y Yang","year":"2016","unstructured":"Yang Y, Lv J, Jiang S, Ma Z, Wang D, Hu W, et al. The emerging role of Toll-like receptor 4 in myocardial inflammation. Cell Death Dis. 2016;7(5):e2234\u2013e2234. https:\/\/doi.org\/10.1038\/cddis.2016.140.","journal-title":"Cell Death Dis"},{"key":"599_CR27","doi-asserted-by":"publisher","unstructured":"Kaur R, Singh V, Kumari P, Singh R, Chopra H, Emran TB. Novel insights on the role of VCAM-1 and ICAM-1: Potential biomarkers for cardiovascular diseases. Ann Med Surg (Lond). 2022;84. https:\/\/doi.org\/10.1016\/j.amsu.2022.104802.","DOI":"10.1016\/j.amsu.2022.104802"},{"key":"599_CR28","doi-asserted-by":"publisher","unstructured":"Mo B, Ding Y, Ji Q. NLRP3 inflammasome in cardiovascular diseases: an update. Front Immunol. 2025;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1550226.","DOI":"10.3389\/fimmu.2025.1550226"},{"issue":"7","key":"599_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.cardfail.2015.04.014","volume":"21","author":"B Butts","year":"2015","unstructured":"Butts B, Gary RA, Dunbar SB, Butler J. The Importance of NLRP3 Inflammasome in Heart Failure. J Card Fail. 2015;21(7):586\u201393. https:\/\/doi.org\/10.1016\/j.cardfail.2015.04.014.","journal-title":"J Card Fail"},{"key":"599_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.16.2055","author":"A Deswal","year":"2001","unstructured":"Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial. Circulation. 2001. https:\/\/doi.org\/10.1161\/01.cir.103.16.2055.","journal-title":"Circulation"},{"key":"599_CR31","doi-asserted-by":"publisher","unstructured":"Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol. 2017;112(3). https:\/\/doi.org\/10.1007\/s00395-017-0622-5.","DOI":"10.1007\/s00395-017-0622-5"},{"key":"599_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939889","author":"S Recalcati","year":"2010","unstructured":"Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol. 2010. https:\/\/doi.org\/10.1002\/eji.200939889.","journal-title":"Eur J Immunol"},{"key":"599_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00275","author":"M de Gaetano","year":"2016","unstructured":"de Gaetano M, Crean D, Barry M, Belton O. M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis. Front Immunol. 2016. https:\/\/doi.org\/10.3389\/fimmu.2016.00275.","journal-title":"Front Immunol"},{"key":"599_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.117.018724","author":"XM Yuan","year":"2018","unstructured":"Yuan XM, Ward LJ, Forssell C, Siraj N, Li W. Carotid atheroma from men has significantly higher levels of inflammation and iron metabolism enabled by macrophages. Stroke. 2018. https:\/\/doi.org\/10.1161\/strokeaha.117.018724.","journal-title":"Stroke"},{"issue":"16","key":"599_CR35","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/eurheartj\/ehab842","volume":"43","author":"S Steffens","year":"2022","unstructured":"Steffens S, Nahrendorf M, Madonna R. Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies. Eur Heart J. 2022;43(16):1533\u201341. https:\/\/doi.org\/10.1093\/eurheartj\/ehab842.","journal-title":"Eur Heart J"},{"key":"599_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10156-z","author":"A Moskalik","year":"2022","unstructured":"Moskalik A, Niderla-Bielinska J, Ratajska A. Multiple roles of cardiac macrophages in heart homeostasis and failure. Heart Fail Rev. 2022. https:\/\/doi.org\/10.1007\/s10741-021-10156-z.","journal-title":"Heart Fail Rev"},{"key":"599_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2705","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013. https:\/\/doi.org\/10.1038\/ni.2705.","journal-title":"Nat Immunol"},{"key":"599_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3324","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux F, Schultze JL, Murray PJ, Ochando J, Biswas SK. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol. 2016. https:\/\/doi.org\/10.1038\/ni.3324.","journal-title":"Nat Immunol"},{"key":"599_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22178-0","author":"J Sugita","year":"2021","unstructured":"Sugita J, Fujiu K, Nakayama Y, Matsubara T, Matsuda J, Oshima T. Cardiac macrophages prevent sudden death during heart stress. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-22178-0.","journal-title":"Nat Commun"},{"key":"599_CR40","doi-asserted-by":"publisher","unstructured":"Anzai A, Ko S, Fukuda K. Immune and Inflammatory Networks in Myocardial Infarction: Current Research and Its Potential Implications for the Clinic. Int J Mol Sci. 2022;23(9). https:\/\/doi.org\/10.3390\/ijms23095214.","DOI":"10.3390\/ijms23095214"},{"key":"599_CR41","doi-asserted-by":"publisher","DOI":"10.1242\/dev.199906","author":"FC Simoes","year":"2022","unstructured":"Simoes FC, Riley PR. Immune cells in cardiac repair and regeneration. Development. 2022. https:\/\/doi.org\/10.1242\/dev.199906.","journal-title":"Development"},{"key":"599_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz336","author":"C Peet","year":"2020","unstructured":"Peet C, Ivetic A, Bromage DI, Shah AM. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2020. https:\/\/doi.org\/10.1093\/cvr\/cvz336.","journal-title":"Cardiovasc Res"},{"key":"599_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw002","author":"M Horckmans","year":"2017","unstructured":"Horckmans M, Ring L, Duchene J, Santovito D, Schloss MJ, Drechsler M. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur Heart J. 2017. https:\/\/doi.org\/10.1093\/eurheartj\/ehw002.","journal-title":"Eur Heart J"},{"key":"599_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317200","author":"E Vafadarnejad","year":"2020","unstructured":"Vafadarnejad E, Rizzo G, Krampert L. Dynamics of Cardiac Neutrophil Diversity in Murine Myocardial Infarction. Circ Res. 2020. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317200.","journal-title":"Circ Res"},{"key":"599_CR45","doi-asserted-by":"publisher","unstructured":"Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S, et al. Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1485222.","DOI":"10.3389\/fimmu.2024.1485222"},{"issue":"2","key":"599_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2015","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2015;73(2):377\u201392. https:\/\/doi.org\/10.1007\/s00018-015-2070-4.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"599_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O'Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365. https:\/\/doi.org\/10.1038\/nri.2016.70.","journal-title":"Nat Rev Immunol"},{"key":"599_CR48","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040568","author":"NS Chandel","year":"2021","unstructured":"Chandel NS. Carbohydrate metabolism. Cold Spring Harb Perspect Biol. 2021. https:\/\/doi.org\/10.1101\/cshperspect.a040568.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"599_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s42255-021-00512-6","volume":"4","author":"OA Cherepanova","year":"2022","unstructured":"Cherepanova OA, Byzova TV. Pentose phosphate pathway drives vascular maturation. Nat Metab. 2022;4(1):15\u20136. https:\/\/doi.org\/10.1038\/s42255-021-00512-6.","journal-title":"Nat Metab"},{"issue":"8","key":"599_CR50","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nat Metab. 2023;5(8):1275\u201389. https:\/\/doi.org\/10.1038\/s42255-023-00863-2.","journal-title":"Nat Metab"},{"key":"599_CR51","doi-asserted-by":"publisher","unstructured":"Dore MP, Parodi G, Portoghese M, Pes GM, Ghose J. The Controversial Role of Glucose\u20106\u2010Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review. Oxid Med Cell Longev. 2021;2021(1). https:\/\/doi.org\/10.1155\/2021\/5529256.","DOI":"10.1155\/2021\/5529256"},{"key":"599_CR52","doi-asserted-by":"publisher","unstructured":"Zodda E, Tura-Ceide O, Mills NL, Tarrag\u00f3-Celada J, Carini M, Thomson TM, et al. Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarction. Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.86260.","DOI":"10.7554\/eLife.86260"},{"issue":"3","key":"599_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1161\/circulationaha.119.044452","volume":"142","author":"R Badolia","year":"2020","unstructured":"Badolia R, Ramadurai DKA, Abel ED, Ferrin P, Taleb I, Shankar TS, et al. The role of nonglycolytic glucose metabolism in myocardial recovery upon mechanical unloading and circulatory support in chronic heart failure. Circulation. 2020;142(3):259\u201374. https:\/\/doi.org\/10.1161\/circulationaha.119.044452.","journal-title":"Circulation"},{"issue":"7","key":"599_CR54","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jacbts.2022.12.010","volume":"8","author":"M DeBerge","year":"2023","unstructured":"DeBerge M, Chaudhary R, Schroth S, Thorp EB. Immunometabolism at the Heart of Cardiovascular Disease. JACC Basic Transl Sci. 2023;8(7):884\u2013904. https:\/\/doi.org\/10.1016\/j.jacbts.2022.12.010.","journal-title":"JACC Basic Transl Sci"},{"key":"599_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2014.07.013","author":"V Infantino","year":"2014","unstructured":"Infantino V, Iacobazzi V, Menga A, Avantaggiati ML, Palmieri F. A key role of the mitochondrial citrate carrier SLC25A1 in TNF-alpha- and IFN-gamma-triggered inflammation. Biochim Biophys Acta. 2014. https:\/\/doi.org\/10.1016\/j.bbagrm.2014.07.013.","journal-title":"Biochim Biophys Acta"},{"key":"599_CR56","doi-asserted-by":"publisher","unstructured":"Zhao SS, Liu J, Wu QC, Zhou XL. Lactate regulates pathological cardiac hypertrophy via histone lactylation modification. J Cell Mol Med. 2024;28(16). https:\/\/doi.org\/10.1111\/jcmm.70022.","DOI":"10.1111\/jcmm.70022"},{"issue":"2","key":"599_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/circulationaha.122.062166","volume":"148","author":"WD Watson","year":"2023","unstructured":"Watson WD, Green PG, Lewis AJM, Arvidsson P, De Maria GL, Arheden H, et al. Retained Metabolic Flexibility of the Failing Human Heart. Circulation. 2023;148(2):109\u201323. https:\/\/doi.org\/10.1161\/circulationaha.122.062166.","journal-title":"Circulation"},{"key":"599_CR58","doi-asserted-by":"publisher","unstructured":"Karwi QG, Uddin GM, Ho KL, Lopaschuk GD. Loss of Metabolic Flexibility in the Failing Heart. Front Cardiovasc Med. 2018;5. https:\/\/doi.org\/10.3389\/fcvm.2018.00068.","DOI":"10.3389\/fcvm.2018.00068"},{"key":"599_CR59","doi-asserted-by":"publisher","unstructured":"Wei S, Binbin L, Yuan W, Zhong Z, Donghai L, Caihua H. \u03b2-Hydroxybutyrate in Cardiovascular Diseases : A Minor Metabolite of Great Expectations. Front Mol Biosci. 2022;9. https:\/\/doi.org\/10.3389\/fmolb.2022.823602.","DOI":"10.3389\/fmolb.2022.823602"},{"key":"599_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005066","author":"LC Gormsen","year":"2017","unstructured":"Gormsen LC, Svart M, Thomsen HH. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study. J Am Heart Assoc. 2017. https:\/\/doi.org\/10.1161\/JAHA.116.005066.","journal-title":"J Am Heart Assoc"},{"key":"599_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1279066","author":"C Gao","year":"2023","unstructured":"Gao C, Hou L. Branched chain amino acids metabolism in heart failure. Front Nutr. 2023. https:\/\/doi.org\/10.3389\/fnut.2023.1279066.","journal-title":"Front Nutr"},{"issue":"4","key":"599_CR62","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajpath.2023.12.006","volume":"194","author":"SK Anand","year":"2024","unstructured":"Anand SK, Governale T-A, Zhang X, Razani B, Yurdagul A, Pattillo CB, et al. Amino Acid Metabolism and Atherosclerotic Cardiovascular Disease. Am J Pathol. 2024;194(4):510\u201324. https:\/\/doi.org\/10.1016\/j.ajpath.2023.12.006.","journal-title":"Am J Pathol"},{"key":"599_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.12.006","author":"YX Mao","year":"2022","unstructured":"Mao YX, Shi D, Li G, Jiang P. Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses. Mol Cell. 2022. https:\/\/doi.org\/10.1016\/j.molcel.2021.12.006.","journal-title":"Mol Cell"},{"key":"599_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00925-7","author":"X Shan","year":"2022","unstructured":"Shan X, Hu PH, Ni LN, Shen L, Zhang YA, Ji ZM. Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis. Cell Mol Immunol. 2022. https:\/\/doi.org\/10.1038\/s41423-022-00925-7.","journal-title":"Cell Mol Immunol"},{"key":"599_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2797-4","author":"M Litvi\u0148ukov\u00e1","year":"2020","unstructured":"Litvi\u0148ukov\u00e1 M, Talavera-L\u00f3pez C, Maatz H. Cells of the adult human heart. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2797-4.","journal-title":"Nature"},{"key":"599_CR66","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.045401","author":"NR Tucker","year":"2020","unstructured":"Tucker NR, Chaffin M, Fleming SJ. Transcriptional and Cellular Diversity of the Human Heart. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.045401.","journal-title":"Circulation"},{"key":"599_CR67","doi-asserted-by":"publisher","unstructured":"Hu Y, Jia H, Cui H, Song J. Application of Spatial Omics in the Cardiovascular System. Research (Wash D C). 2025;8. https:\/\/doi.org\/10.34133\/research.0628.","DOI":"10.34133\/research.0628"},{"key":"599_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.09.013","author":"MN Artyomov","year":"2020","unstructured":"Artyomov MN, Van den Bossche J. Immunometabolism in the single-cell era. Cell Metab. 2020. https:\/\/doi.org\/10.1016\/j.cmet.2020.09.013.","journal-title":"Cell Metab"},{"key":"599_CR69","doi-asserted-by":"publisher","unstructured":"Tian H, Zhao X, Zhang Y, Xia Z. Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury. Biomed Pharmacother. 2023;163. https:\/\/doi.org\/10.1016\/j.biopha.2023.114827.","DOI":"10.1016\/j.biopha.2023.114827"},{"key":"599_CR70","doi-asserted-by":"publisher","unstructured":"Chen S, Zou Y, Song C, Cao K, Cai K, Wu Y, et al. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Res Cardiol. 2023;118(1). https:\/\/doi.org\/10.1007\/s00395-023-01018-w.","DOI":"10.1007\/s00395-023-01018-w"},{"issue":"4","key":"599_CR71","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41422-020-0301-1","volume":"30","author":"J Saravia","year":"2020","unstructured":"Saravia J, Raynor JL, Chapman NM, Lim SA, Chi H. Signaling networks in immunometabolism. Cell Res. 2020;30(4):328\u201342. https:\/\/doi.org\/10.1038\/s41422-020-0301-1.","journal-title":"Cell Res"},{"issue":"19","key":"599_CR72","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/1873-3468.12711","volume":"591","author":"M Linke","year":"2017","unstructured":"Linke M, Fritsch SD, Sukhbaatar N, Hengstschl\u00e4ger M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591(19):3089\u2013103. https:\/\/doi.org\/10.1002\/1873-3468.12711.","journal-title":"FEBS Lett"},{"key":"599_CR73","doi-asserted-by":"publisher","unstructured":"Chen J, Liu B, Yao X, Yang X, Sun J, Yi J, et al. AMPK\/SIRT1\/PGC\u20101\u03b1 Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy. CNS Neurosci Ther. 2025;31(11). https:\/\/doi.org\/10.1111\/cns.70657.","DOI":"10.1111\/cns.70657"},{"key":"599_CR74","doi-asserted-by":"publisher","unstructured":"Le Menn G, Neels JG. Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases. Int J Mol Sci. 2018;19(6). https:\/\/doi.org\/10.3390\/ijms19061575.","DOI":"10.3390\/ijms19061575"},{"key":"599_CR75","doi-asserted-by":"publisher","unstructured":"He F, Ru X, Wen T. NRF2, a Transcription Factor for Stress Response and Beyond. Int J Mol Sci. 2020;21(13). https:\/\/doi.org\/10.3390\/ijms21134777.","DOI":"10.3390\/ijms21134777"},{"key":"599_CR76","doi-asserted-by":"publisher","unstructured":"Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G. The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. MedComm. 2026;7(3). https:\/\/doi.org\/10.1002\/mco2.70660.","DOI":"10.1002\/mco2.70660"},{"key":"599_CR77","doi-asserted-by":"publisher","unstructured":"Cui Y, Chen J, Zhang Z, Shi H, Sun W, Yi Q. The role of AMPK in macrophage metabolism, function and polarisation. J Transl Med. 2023;21(1). https:\/\/doi.org\/10.1186\/s12967-023-04772-6.","DOI":"10.1186\/s12967-023-04772-6"},{"key":"599_CR78","doi-asserted-by":"publisher","unstructured":"Fedor A, Bryniarski K, Nazimek K. mTOR Signaling in Macrophages: All Depends on the Context. Int J Mol Sci. 2025;26(15). https:\/\/doi.org\/10.3390\/ijms26157598.","DOI":"10.3390\/ijms26157598"},{"key":"599_CR79","doi-asserted-by":"publisher","unstructured":"Lampiasi N, Russo R. HIF-1\u03b1 as a Central Regulator of Monocyte Responses to Hypoxia. Biology (Basel). 2026;15(3). https:\/\/doi.org\/10.3390\/biology15030213.","DOI":"10.3390\/biology15030213"},{"key":"599_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101661","volume":"68","author":"IR Phair","year":"2023","unstructured":"Phair IR, Nisr RB, Howden AJM, Sovakova M, Alqurashi N, Foretz M, et al. AMPK integrates metabolite and kinase-based immunometabolic control in macrophages. Mol Metab. 2023;68:101661. https:\/\/doi.org\/10.1016\/j.molmet.2022.101661.","journal-title":"Mol Metab"},{"key":"599_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.11.061","author":"BC Zhang","year":"2018","unstructured":"Zhang BC, Ma YF, Xiang CH. SIRT2 decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice by modulating macrophage polarization. Biomed Pharmacother. 2018. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.061.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"599_CR82","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/circresaha.120.317046","volume":"128","author":"D Tong","year":"2021","unstructured":"Tong D, Schiattarella GG, Jiang N, Altamirano F, Szweda PA, Elnwasany A, et al. NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction. Circ Res. 2021;128(11):1629\u201341. https:\/\/doi.org\/10.1161\/circresaha.120.317046.","journal-title":"Circ Res"},{"key":"599_CR83","doi-asserted-by":"publisher","unstructured":"Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 2016;5. https:\/\/doi.org\/10.7554\/eLife.11612.","DOI":"10.7554\/eLife.11612"},{"key":"599_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.09.037","author":"V Infantino","year":"2013","unstructured":"Infantino V, Iacobazzi V, Palmieri F, Menga A. ATP-citrate lyase is essential for macrophage inflammatory response. Biochem Biophys Res Commun. 2013. https:\/\/doi.org\/10.1016\/j.bbrc.2013.09.037.","journal-title":"Biochem Biophys Res Commun"},{"key":"599_CR85","doi-asserted-by":"publisher","unstructured":"Toobian D, Ghosh P, Katkar GD. Parsing the Role of PPARs in Macrophage Processes. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.783780.","DOI":"10.3389\/fimmu.2021.783780"},{"key":"599_CR86","doi-asserted-by":"publisher","first-page":"1254317","DOI":"10.3389\/fphar.2023.1254317","volume":"14","author":"L Yu","year":"2023","unstructured":"Yu L, Gao Y, Aaron N, Qiang L. A glimpse of the connection between PPAR\u03b3 and macrophage. Front Pharmacol. 2023;14:1254317. https:\/\/doi.org\/10.3389\/fphar.2023.1254317.","journal-title":"Front Pharmacol"},{"key":"599_CR87","doi-asserted-by":"publisher","unstructured":"Ngo V, Duennwald ML. Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Antioxidants (Basel). 2022;11(12). https:\/\/doi.org\/10.3390\/antiox11122345.","DOI":"10.3390\/antiox11122345"},{"issue":"7699","key":"599_CR88","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556(7699):113\u20137. https:\/\/doi.org\/10.1038\/nature25986.","journal-title":"Nature"},{"key":"599_CR89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200667","author":"M DeBerge","year":"2021","unstructured":"DeBerge M, Lantz C, Dehn S, Sullivan DP, van der Laan AM, Niessen HWM. Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20200667.","journal-title":"J Exp Med"},{"key":"599_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.10.003","author":"A Olona","year":"2022","unstructured":"Olona A, Leishman S, Anand PK. The NLRP3 inflammasome: regulation by metabolic signals. Trends Immunol. 2022. https:\/\/doi.org\/10.1016\/j.it.2022.10.003.","journal-title":"Trends Immunol"},{"key":"599_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00270","author":"C Diskin","year":"2018","unstructured":"Diskin C, Palsson-McDermott EM. Metabolic modulation in macrophage effector function. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.00270.","journal-title":"Front Immunol"},{"key":"599_CR92","doi-asserted-by":"publisher","unstructured":"Langston PK, Shibata M, Horng T. Metabolism Supports Macrophage Activation. Front Immunol. 2017;8. https:\/\/doi.org\/10.3389\/fimmu.2017.00061.","DOI":"10.3389\/fimmu.2017.00061"},{"key":"599_CR93","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12603","author":"S Saha","year":"2017","unstructured":"Saha S, Shalova IN, Biswas SK. Metabolic regulation of macrophage phenotype and function. Immunol Rev. 2017. https:\/\/doi.org\/10.1111\/imr.12603.","journal-title":"Immunol Rev"},{"key":"599_CR94","doi-asserted-by":"publisher","unstructured":"Viola A, Munari F, S\u00e1nchez-Rodr\u00edguez R, Scolaro T, Castegna A. The Metabolic Signature of Macrophage Responses. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.01462.","DOI":"10.3389\/fimmu.2019.01462"},{"key":"599_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.017","author":"LAJ O'Neill","year":"2015","unstructured":"O\u2019Neill LAJ. A broken Krebs cycle in macrophages. Immunity. 2015. https:\/\/doi.org\/10.1016\/j.immuni.2015.02.017.","journal-title":"Immunity"},{"issue":"7444","key":"599_CR96","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 2013;496(7444):238\u201342. https:\/\/doi.org\/10.1038\/nature11986.","journal-title":"Nature"},{"issue":"1","key":"599_CR97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"M Palsson-McDermott Eva","year":"2015","unstructured":"Palsson-McDermott Eva M, Curtis Anne M, Goel G, Lauterbach Mario AR, Sheedy Frederick J, Gleeson Laura E, et al. Pyruvate Kinase M2 Regulates Hif-1\u03b1 Activity and IL-1\u03b2 Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. Cell Metab. 2015;21(1):65\u201380. https:\/\/doi.org\/10.1016\/j.cmet.2014.12.005.","journal-title":"Cell Metab"},{"key":"599_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13280","author":"M Xie","year":"2016","unstructured":"Xie M, Yu Y, Kang R, Zhu S, Yang LC, Zeng L. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat Commun. 2016. https:\/\/doi.org\/10.1038\/ncomms13280.","journal-title":"Nat Commun"},{"key":"599_CR99","doi-asserted-by":"publisher","DOI":"10.7554\/elife.13663","author":"LE Sanman","year":"2016","unstructured":"Sanman LE, Qian Y, Eisele NA, Ng TM, van der Linden WA, Monack DM. Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell death. Elife. 2016. https:\/\/doi.org\/10.7554\/elife.13663.","journal-title":"Elife"},{"issue":"2","key":"599_CR100","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages. Cell. 2016;167(2):457-470.e413. https:\/\/doi.org\/10.1016\/j.cell.2016.08.064.","journal-title":"Cell"},{"issue":"1","key":"599_CR101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent Emma E, Loginicheva E, et al. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. Cell Metab. 2016;24(1):158\u201366. https:\/\/doi.org\/10.1016\/j.cmet.2016.06.004.","journal-title":"Cell Metab"},{"issue":"8","key":"599_CR102","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s13238-019-0636-x","volume":"10","author":"P Li","year":"2019","unstructured":"Li P, Deng X, Luo J, Chen Y, Bi G, Gong F, et al. ATP6V0d2 mediates leucine-induced mTORC1 activation and polarization of macrophages. Protein Cell. 2019;10(8):615\u20139. https:\/\/doi.org\/10.1007\/s13238-019-0636-x.","journal-title":"Protein Cell"},{"issue":"3","key":"599_CR103","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2010","unstructured":"Nakahira K, Haspel JA, Rathinam VAK, Lee S-J, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2010;12(3):222\u201330. https:\/\/doi.org\/10.1038\/ni.1980.","journal-title":"Nat Immunol"},{"issue":"3","key":"599_CR104","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada K, Crother Timothy R, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis. Immunity. 2012;36(3):401\u201314. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.009.","journal-title":"Immunity"},{"key":"599_CR105","doi-asserted-by":"publisher","DOI":"10.1172\/jci159498","author":"SS Cai","year":"2023","unstructured":"Cai SS, Zhao MY, Zhou B, Yoshii A, Bugg D, Villet O. Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/jci159498.","journal-title":"J Clin Invest"},{"issue":"6","key":"599_CR106","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","volume":"19","author":"GJ Koelwyn","year":"2018","unstructured":"Koelwyn GJ, Corr EM, Erbay E, Moore KJ. Regulation of macrophage immunometabolism in atherosclerosis. Nat Immunol. 2018;19(6):526\u201337. https:\/\/doi.org\/10.1038\/s41590-018-0113-3.","journal-title":"Nat Immunol"},{"key":"599_CR107","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.119.312802","author":"TJ Barrett","year":"2020","unstructured":"Barrett TJ. Macrophages in atherosclerosis regression. Arterioscler Thromb Vasc Biol. 2020. https:\/\/doi.org\/10.1161\/atvbaha.119.312802.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"599_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00471-y","author":"J Merlin","year":"2021","unstructured":"Merlin J, Ivanov S, Dumont A, Sergushichev A, Gall J, Stunault M. Non-canonical glutamine transamination sustains efferocytosis by coupling redox buffering to oxidative phosphorylation. Nat Metab. 2021. https:\/\/doi.org\/10.1038\/s42255-021-00471-y.","journal-title":"Nat Metab"},{"issue":"2","key":"599_CR109","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","volume":"29","author":"S Zhang","year":"2019","unstructured":"Zhang S, Weinberg S, DeBerge M, Gainullina A, Schipma M, Kinchen JM, et al. Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair. Cell Metab. 2019;29(2):443-456.e445. https:\/\/doi.org\/10.1016\/j.cmet.2018.12.004.","journal-title":"Cell Metab"},{"key":"599_CR110","doi-asserted-by":"publisher","unstructured":"Sun L, Fu J, Zhou Y. Metabolism Controls the Balance of Th17\/T-Regulatory Cells. Front Immunol. 2017;8. https:\/\/doi.org\/10.3389\/fimmu.2017.01632.","DOI":"10.3389\/fimmu.2017.01632"},{"issue":"7","key":"599_CR111","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1\u03b1\u2013dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208(7):1367\u201376. https:\/\/doi.org\/10.1084\/jem.20110278.","journal-title":"J Exp Med"},{"issue":"6","key":"599_CR112","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets. J Immunol. 2011;186(6):3299\u2013303. https:\/\/doi.org\/10.4049\/jimmunol.1003613.","journal-title":"J Immunol"},{"issue":"11","key":"599_CR113","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014;20(11):1327\u201333. https:\/\/doi.org\/10.1038\/nm.3704.","journal-title":"Nat Med"},{"key":"599_CR114","doi-asserted-by":"publisher","unstructured":"Cluxton D, Petrasca A, Moran B, Fletcher JM. Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.00115.","DOI":"10.3389\/fimmu.2019.00115"},{"issue":"3","key":"599_CR115","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","volume":"28","author":"B Raud","year":"2018","unstructured":"Raud B, Roy DG, Divakaruni AS, Tarasenko TN, Franke R, Ma EH, et al. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation. Cell Metab. 2018;28(3):504-515.e507. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.002.","journal-title":"Cell Metab"},{"key":"599_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00251-y","author":"Y Liu","year":"2021","unstructured":"Liu Y, Xu R, Gu H, Zhang E, Qu J, Cao W. Metabolic reprogramming in macrophage responses. Biomark Res. 2021. https:\/\/doi.org\/10.1186\/s40364-020-00251-y.","journal-title":"Biomark Res"},{"key":"599_CR117","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2021.01.036","volume":"165","author":"M Dambrova","year":"2021","unstructured":"Dambrova M, Zuurbier CJ, Borutaite V, Liepinsh E, Makrecka-Kuka M. Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia\/reperfusion injury. Free Radic Biol Med. 2021;165:24\u201337. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.01.036.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"599_CR118","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1111\/jcmm.15180","volume":"24","author":"CJ Zuurbier","year":"2020","unstructured":"Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, et al. Cardiac metabolism as a driver and therapeutic target of myocardial infarction. J Cell Mol Med. 2020;24(11):5937\u201354. https:\/\/doi.org\/10.1111\/jcmm.15180.","journal-title":"J Cell Mol Med"},{"key":"599_CR119","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2023.05.014","volume":"205","author":"P S\u00e1nchez-P\u00e9rez","year":"2023","unstructured":"S\u00e1nchez-P\u00e9rez P, Mata A, Torp M-K, L\u00f3pez-Bernardo E, Heiestad CM, Aronsen JM, et al. Energy substrate metabolism, mitochondrial structure and oxidative stress after cardiac ischemia-reperfusion in mice lacking UCP3. Free Radic Biol Med. 2023;205:244\u201361. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.05.014.","journal-title":"Free Radic Biol Med"},{"key":"599_CR120","doi-asserted-by":"publisher","unstructured":"Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling. Biochim Biophys Acta Mol Basis Dis. 2020;1866(7). https:\/\/doi.org\/10.1016\/j.bbadis.2020.165768.","DOI":"10.1016\/j.bbadis.2020.165768"},{"issue":"12","key":"599_CR121","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.7150\/thno.44836","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Xiong Z, Yan W, Gao E, Cheng H, Wu G, et al. Branched chain amino acids exacerbate myocardial ischemia\/reperfusion vulnerability via enhancing GCN2\/ATF6\/PPAR-\u03b1 pathway-dependent fatty acid oxidation. Theranostics. 2020;10(12):5623\u201340. https:\/\/doi.org\/10.7150\/thno.44836.","journal-title":"Theranostics"},{"key":"599_CR122","doi-asserted-by":"publisher","unstructured":"Wu G, Guo Y, Li M, Li C, Tan Y, Li Y, et al. Exercise Enhances Branched-Chain Amino Acid Catabolism and Decreases Cardiac Vulnerability to Myocardial Ischemic Injury. Cells. 2022;11(10). https:\/\/doi.org\/10.3390\/cells11101706.","DOI":"10.3390\/cells11101706"},{"key":"599_CR123","doi-asserted-by":"publisher","unstructured":"Yu J-y, Cao N, Rau CD, Lee R-P, Yang J, Flach RJR, et al. Cell-autonomous effect of cardiomyocyte branched-chain amino acid catabolism in heart failure in mice. Acta Pharmacol Sin. 2023;44(7):1380\u20131390. https:\/\/doi.org\/10.1038\/s41401-023-01076-9.","DOI":"10.1038\/s41401-023-01076-9"},{"issue":"3","key":"599_CR124","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/circresaha.121.319817","volume":"131","author":"Z Li","year":"2022","unstructured":"Li Z, Xia H, Sharp TE, LaPenna KB, Elrod JW, Casin KM, et al. Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure. Circ Res. 2022;131(3):222\u201335. https:\/\/doi.org\/10.1161\/circresaha.121.319817.","journal-title":"Circ Res"},{"issue":"3","key":"599_CR125","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 2021;33(3):629-648.e610. https:\/\/doi.org\/10.1016\/j.cmet.2020.12.003.","journal-title":"Cell Metab"},{"issue":"15","key":"599_CR126","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400283r","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang X, Liu X, Wu W, Liao L, Zhou M, Wang X, et al. Hypoxia activates macrophage-NLRP3 inflammasome promoting atherosclerosis via PFKFB3-driven glycolysis. FASEB J. 2024;38(15):e23854. https:\/\/doi.org\/10.1096\/fj.202400283r.","journal-title":"FASEB J"},{"issue":"6337","key":"599_CR127","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017;356(6337):513\u20139. https:\/\/doi.org\/10.1126\/science.aal3535.","journal-title":"Science"},{"key":"599_CR128","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eng.2024.05.015","volume":"42","author":"X Chen","year":"2024","unstructured":"Chen X, Du Z, Guo D, Guo J, Sun Q, Liu T, et al. Activation of the Macrophage-Associated Inflammasome Exacerbates Myocardial Fibrosis Through the 15-HETE-Mediated Pathway in Acute Myocardial Infarction. Engineering (Beijing). 2024;42:143\u201356. https:\/\/doi.org\/10.1016\/j.eng.2024.05.015.","journal-title":"Engineering (Beijing)"},{"key":"599_CR129","doi-asserted-by":"publisher","unstructured":"Song J, Zhang Y, Frieler RA, Andren A, Wood S, Tyrrell DJ, et al. Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice. J Clin Invest. 2023;134(3). https:\/\/doi.org\/10.1172\/jci173034.","DOI":"10.1172\/jci173034"},{"issue":"3","key":"599_CR130","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/atvbaha.120.315758","volume":"41","author":"Z Hosseini","year":"2021","unstructured":"Hosseini Z, Marinello M, Decker C, Sansbury BE, Sadhu S, Gerlach BD, et al. Resolvin D1 Enhances Necroptotic Cell Clearance Through Promoting Macrophage Fatty Acid Oxidation and Oxidative Phosphorylation. Arterioscler Thromb Vasc Biol. 2021;41(3):1062\u201375. https:\/\/doi.org\/10.1161\/atvbaha.120.315758.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"599_CR131","doi-asserted-by":"publisher","unstructured":"Hohensinner PJ, Lenz M, Haider P, Mayer J, Richter M, Kaun C, et al. Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation. Biochem Pharmacol. 2021;190. https:\/\/doi.org\/10.1016\/j.bcp.2021.114634.","DOI":"10.1016\/j.bcp.2021.114634"},{"key":"599_CR132","doi-asserted-by":"publisher","unstructured":"Zuo W, Sun R, Ji Z, Ma G. Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction. Cell Mol Biol Lett. 2023;28(1). https:\/\/doi.org\/10.1186\/s11658-023-00491-4.","DOI":"10.1186\/s11658-023-00491-4"},{"key":"599_CR133","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020452","author":"NV Mushenkova","year":"2022","unstructured":"Mushenkova NV, Nikiforov NG, Melnichenko AA, Kalmykov V, Shakhpazyan NK, Orekhova VA. Functional phenotypes of intraplaque macrophages and their distinct roles in atherosclerosis development and atheroinflammation. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10020452.","journal-title":"Biomedicines"},{"key":"599_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.10.852","author":"AV Finn","year":"2012","unstructured":"Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao XQ. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol. 2012. https:\/\/doi.org\/10.1016\/j.jacc.2011.10.852.","journal-title":"J Am Coll Cardiol"},{"key":"599_CR135","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.111.247577","author":"JJ Boyle","year":"2012","unstructured":"Boyle JJ, Johns M, Kampfer T, Nguyen AT, Game L, Schaer DJ. Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection. Circ Res. 2012. https:\/\/doi.org\/10.1161\/circresaha.111.247577.","journal-title":"Circ Res"},{"issue":"8","key":"599_CR136","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/circresaha.123.323826","volume":"134","author":"OL Manzo","year":"2024","unstructured":"Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, et al. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis. Circ Res. 2024;134(8):990\u20131005. https:\/\/doi.org\/10.1161\/circresaha.123.323826.","journal-title":"Circ Res"},{"issue":"23","key":"599_CR137","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/circulationaha.124.071741","volume":"151","author":"X Guo","year":"2025","unstructured":"Guo X, Huang C, Zhang L, Hu G, Du Y, Chen X, et al. Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF. Circulation. 2025;151(23):1651\u201366. https:\/\/doi.org\/10.1161\/circulationaha.124.071741.","journal-title":"Circulation"},{"key":"599_CR138","doi-asserted-by":"publisher","unstructured":"Chen Z-T, Gao Q-Y, Wu M-X, Wang M, Sun R-L, Jiang Y, et al. Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation. Front Cardiovasc Med. 2021;8. https:\/\/doi.org\/10.3389\/fcvm.2021.701745.","DOI":"10.3389\/fcvm.2021.701745"},{"key":"599_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2012.158","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013. https:\/\/doi.org\/10.1038\/nrcardio.2012.158.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"599_CR140","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s44161-022-00208-4","volume":"2","author":"MAC Depuydt","year":"2023","unstructured":"Depuydt MAC, Schaftenaar FH, Prange KHM, Boltjes A, Hemme E, Delfos L, et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat Cardiovasc Res. 2023;2(2):112\u201325. https:\/\/doi.org\/10.1038\/s44161-022-00208-4.","journal-title":"Nat Cardiovasc Res"},{"issue":"8","key":"599_CR141","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/circresaha.122.321094","volume":"131","author":"K Nitz","year":"2022","unstructured":"Nitz K, Lacy M, Bianchini M, Wichapong K, K\u00fcc\u00fckg\u00f6ze IA, Bonfiglio CA, et al. The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell Function. Circ Res. 2022;131(8):701\u201312. https:\/\/doi.org\/10.1161\/circresaha.122.321094.","journal-title":"Circ Res"},{"key":"599_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.07.016","author":"A Hooftman","year":"2020","unstructured":"Hooftman A, Angiari S, Hester S, Corcoran SE, Runtsch MC, Ling C. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 2020. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.016.","journal-title":"Cell Metab"},{"issue":"7702","key":"599_CR143","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","volume":"556","author":"M Bambouskova","year":"2018","unstructured":"Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, et al. Electrophilic properties of itaconate and derivatives regulate the I\u03baB\u03b6\u2013ATF3 inflammatory axis. Nature. 2018;556(7702):501\u20134. https:\/\/doi.org\/10.1038\/s41586-018-0052-z.","journal-title":"Nature"},{"key":"599_CR144","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb9818","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang BW, Nemmara VV. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020. https:\/\/doi.org\/10.1126\/science.abb9818.","journal-title":"Science"},{"key":"599_CR145","doi-asserted-by":"publisher","unstructured":"Feng T, Zhao X, Gu P, Yang W, Wang C, Guo Q, et al. Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2. Nat Commun. 2022;13(1). https:\/\/doi.org\/10.1038\/s41467-022-32871-3.","DOI":"10.1038\/s41467-022-32871-3"},{"issue":"7","key":"599_CR146","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1053\/j.gastro.2014.03.014","volume":"146","author":"R Hoque","year":"2014","unstructured":"Hoque R, Farooq A, Ghani A, Gorelick F, Mehal WZ. Lactate Reduces Liver and Pancreatic Injury in Toll-Like Receptor\u2013 and Inflammasome-Mediated Inflammation via GPR81-Mediated Suppression of Innate Immunity. Gastroenterology. 2014;146(7):1763\u201374. https:\/\/doi.org\/10.1053\/j.gastro.2014.03.014.","journal-title":"Gastroenterology"},{"key":"599_CR147","doi-asserted-by":"publisher","unstructured":"Yang K, Xu J, Fan M, Tu F, Wang X, Ha T, et al. Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-\u03baB Activation via GPR81-Mediated Signaling. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.587913.","DOI":"10.3389\/fimmu.2020.587913"},{"key":"599_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0259-8","author":"LB Ivashkiv","year":"2020","unstructured":"Ivashkiv LB. The hypoxia-lactate axis tempers inflammation. Nat Rev Immunol. 2020. https:\/\/doi.org\/10.1038\/s41577-019-0259-8.","journal-title":"Nat Rev Immunol"},{"issue":"7779","key":"599_CR149","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"issue":"3","key":"599_CR150","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"Y-H Youm","year":"2015","unstructured":"Youm Y-H, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome\u2013mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139. https:\/\/doi.org\/10.1038\/nm.3804.","journal-title":"Nat Med"},{"key":"599_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2023.100677","author":"H Neudorf","year":"2024","unstructured":"Neudorf H, Little JP. Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: a narrative review. Biomed J. 2024. https:\/\/doi.org\/10.1016\/j.bj.2023.100677.","journal-title":"Biomed J"},{"key":"599_CR152","doi-asserted-by":"publisher","unstructured":"Neudorf H, Myette-C\u00f4t\u00e9 \u00c9, P. Little J. The Impact of Acute Ingestion of a Ketone Monoester Drink on LPS-Stimulated NLRP3 Activation in Humans with Obesity. Nutrients. 2020;12(3). https:\/\/doi.org\/10.3390\/nu12030854.","DOI":"10.3390\/nu12030854"},{"key":"599_CR153","doi-asserted-by":"publisher","unstructured":"Borodzicz-Ja\u017cd\u017cyk S, Ja\u017cd\u017cyk P, \u0141ysik W, Cudnoch-J\u0229drzejewska A, Czarzasta K. Sphingolipid metabolism and signaling in cardiovascular diseases. Front Cardiovasc Med. 2022;9. https:\/\/doi.org\/10.3389\/fcvm.2022.915961.","DOI":"10.3389\/fcvm.2022.915961"},{"issue":"2","key":"599_CR154","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm Y-H, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179\u201388. https:\/\/doi.org\/10.1038\/nm.2279.","journal-title":"Nat Med"},{"key":"599_CR155","doi-asserted-by":"publisher","unstructured":"Wang Y, Wang C, He Q, Chen G, Yu J, Cang J, et al. Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages via TWIK2-mediated potassium efflux. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1090202.","DOI":"10.3389\/fimmu.2023.1090202"},{"key":"599_CR156","doi-asserted-by":"publisher","unstructured":"Syed SN, Weigert A, Br\u00fcne B. Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction. Int J Mol Sci. 2020;21(13). https:\/\/doi.org\/10.3390\/ijms21134733.","DOI":"10.3390\/ijms21134733"},{"key":"599_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05060-x","author":"C Kuppe","year":"2022","unstructured":"Kuppe C, Ramirez Flores RO, Li Z. Spatial multi-omic map of human myocardial infarction. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-05060-x.","journal-title":"Nature"},{"key":"599_CR158","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43882","author":"N Farbehi","year":"2019","unstructured":"Farbehi N, Patrick R, Dorison A. Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. Elife. 2019. https:\/\/doi.org\/10.7554\/eLife.43882.","journal-title":"Elife"},{"key":"599_CR159","doi-asserted-by":"publisher","unstructured":"Zhuang L, Wang Y, Chen Z, Li Z, Wang Z, Jia K, et al. Global Characteristics and Dynamics of Single Immune Cells After Myocardial Infarction. J Am Heart Assoc. 2022;11(24). https:\/\/doi.org\/10.1161\/jaha.122.027228.","DOI":"10.1161\/jaha.122.027228"},{"key":"599_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac113","author":"G Rizzo","year":"2023","unstructured":"Rizzo G, Gropper J, Piollet M, Vafadarnejad E, Rizakou A, Bandi SR. Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction. Cardiovasc Res. 2023. https:\/\/doi.org\/10.1093\/cvr\/cvac113.","journal-title":"Cardiovasc Res"},{"key":"599_CR161","doi-asserted-by":"publisher","unstructured":"Mouton AJ, Aitken NM, Moak SP, do Carmo JM, da Silva AA, Omoto ACM. Temporal changes in glucose metabolism reflect polarization in resident and monocyte-derived macrophages after myocardial infarction. Front Cardiovasc Med. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1136252.","DOI":"10.3389\/fcvm.2023.1136252"},{"key":"599_CR162","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-018-0686-x","author":"AJ Mouton","year":"2018","unstructured":"Mouton AJ, DeLeon-Pennell KY, Gonzalez OJR, Flynn ER, Freeman TC, Saucerman JJ. Mapping macrophage polarization over the myocardial infarction time continuum. Basic Res Cardiol. 2018. https:\/\/doi.org\/10.1007\/s00395-018-0686-x.","journal-title":"Basic Res Cardiol"},{"key":"599_CR163","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0272-2","author":"SA Dick","year":"2019","unstructured":"Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol. 2019. https:\/\/doi.org\/10.1038\/s41590-018-0272-2.","journal-title":"Nat Immunol"},{"key":"599_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32284-2","author":"SH Jung","year":"2022","unstructured":"Jung SH, Hwang BH, Shin S, Park EH, Park SH, Kim CW. Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-32284-2.","journal-title":"Nat Commun"},{"key":"599_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-023-01252-8","author":"SY Gong","year":"2024","unstructured":"Gong SY, Zhai M, Shi JY, Yu GY, Lei ZJ, Shi YF. TREM2 macrophage promotes cardiac repair in myocardial infarction by reprogramming metabolism via SLC25A53. Cell Death Differ. 2024. https:\/\/doi.org\/10.1038\/s41418-023-01252-8.","journal-title":"Cell Death Differ"},{"key":"599_CR166","doi-asserted-by":"publisher","unstructured":"Pasdois P, Parker JE, Halestrap AP. Extent of Mitochondrial Hexokinase II Dissociation During Ischemia Correlates With Mitochondrial Cytochrome c Release, Reactive Oxygen Species Production, and Infarct Size on Reperfusion. J Am Heart Assoc. 2013;2(1). https:\/\/doi.org\/10.1161\/jaha.112.005645.","DOI":"10.1161\/jaha.112.005645"},{"issue":"7","key":"599_CR167","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tem.2019.04.011","volume":"30","author":"N Rabbani","year":"2019","unstructured":"Rabbani N, Thornalley PJ. Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia-Reperfusion Injury. Trends Endocrinol Metab. 2019;30(7):419\u201331. https:\/\/doi.org\/10.1016\/j.tem.2019.04.011.","journal-title":"Trends Endocrinol Metab"},{"key":"599_CR168","doi-asserted-by":"publisher","unstructured":"Liu S, Bi Y, Han T, Li YE, Wang Q, Wu NN, et al. The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5\/MAVS\/NLRP3 axis. Cell Discov. 2024;10(1). https:\/\/doi.org\/10.1038\/s41421-023-00622-3.","DOI":"10.1038\/s41421-023-00622-3"},{"key":"599_CR169","doi-asserted-by":"publisher","unstructured":"Shen S, He F, Cheng C, Xu B, Sheng J. Uric acid aggravates myocardial ischemia\u2013reperfusion injury via ROS\/NLRP3 pyroptosis pathway. Biomed Pharmacother. 2021;133. https:\/\/doi.org\/10.1016\/j.biopha.2020.110990.","DOI":"10.1016\/j.biopha.2020.110990"},{"key":"599_CR170","doi-asserted-by":"publisher","unstructured":"Papatheodorou I, Makrecka-Kuka M, Kuka J, Liepinsh E, Dambrova M, Lazou A. Pharmacological activation of PPAR\u03b2\/\u03b4 preserves mitochondrial respiratory function in ischemia\/reperfusion via stimulation of fatty acid oxidation-linked respiration and PGC-1\u03b1\/NRF-1 signaling. Front Endocrinol (Lausanne). 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.941822.","DOI":"10.3389\/fendo.2022.941822"},{"key":"599_CR171","doi-asserted-by":"publisher","unstructured":"Mouton AJ, Aitken NM, Morato JG, O'Quinn KR, do Carmo JM, da Silva AA, et al. Glutamine metabolism improves left ventricular function but not macrophage-mediated inflammation following myocardial infarction. Am J Physiol Cell Physiol. 2024;327(3):C571-C586. https:\/\/doi.org\/10.1152\/ajpcell.00272.2024.","DOI":"10.1152\/ajpcell.00272.2024"},{"key":"599_CR172","doi-asserted-by":"publisher","unstructured":"Actis Dato V, Lange S, Cho Y. Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases. Int J Mol Sci. 2024;25(2). https:\/\/doi.org\/10.3390\/ijms25021211.","DOI":"10.3390\/ijms25021211"},{"issue":"15","key":"599_CR173","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/circulationaha.122.061846","volume":"147","author":"VS Hahn","year":"2023","unstructured":"Hahn VS, Petucci C, Kim M-S, Bedi KC, Wang H, Mishra S, et al. Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction. Circulation. 2023;147(15):1147\u201361. https:\/\/doi.org\/10.1161\/circulationaha.122.061846.","journal-title":"Circulation"},{"key":"599_CR174","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.109.931451","author":"D Westermann","year":"2011","unstructured":"Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011. https:\/\/doi.org\/10.1161\/circheartfailure.109.931451.","journal-title":"Circ Heart Fail"},{"key":"599_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.06.031","author":"A Alogna","year":"2023","unstructured":"Alogna A, Koepp KE, Sabbah M, Netto JME, Jensen MD, Kirkland JL. Interleukin-6 in patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2023. https:\/\/doi.org\/10.1016\/j.jchf.2023.06.031.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"599_CR176","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jacbts.2022.08.003","volume":"8","author":"H Liu","year":"2023","unstructured":"Liu H, Huang Y, Zhao Y, Kang G-J, Feng F, Wang X, et al. Inflammatory Macrophage Interleukin-1\u03b2 Mediates High-Fat Diet-Induced Heart Failure With Preserved Ejection Fraction. JACC Basic Transl Sci. 2023;8(2):174\u201385. https:\/\/doi.org\/10.1016\/j.jacbts.2022.08.003.","journal-title":"JACC Basic Transl Sci"},{"key":"599_CR177","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.122.062984","author":"C Panico","year":"2024","unstructured":"Panico C, Felicetta A, Kunderfranco P, Cremonesi M, Salvarani N, Carullo P. Single-cell RNA sequencing reveals metabolic stress-dependent activation of cardiac macrophages in a model of dyslipidemia-induced diastolic dysfunction. Circulation. 2024. https:\/\/doi.org\/10.1161\/circulationaha.122.062984.","journal-title":"Circulation"},{"issue":"11","key":"599_CR178","doi-asserted-by":"publisher","first-page":"6054","DOI":"10.1172\/jci138538","volume":"130","author":"B Zhou","year":"2020","unstructured":"Zhou B, Wang DD-H, Qiu Y, Airhart S, Liu Y, Stempien-Otero A, et al. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest. 2020;130(11):6054\u201363. https:\/\/doi.org\/10.1172\/jci138538.","journal-title":"J Clin Invest"},{"key":"599_CR179","doi-asserted-by":"publisher","unstructured":"Aizawa K, Ikeda A, Tomida S, Hino K, Sugita Y, Hirose T, et al. A Potent PDK4 Inhibitor for Treatment of Heart Failure with Reduced Ejection Fraction. Cells. 2023;13(1). https:\/\/doi.org\/10.3390\/cells13010087.","DOI":"10.3390\/cells13010087"},{"key":"599_CR180","doi-asserted-by":"publisher","unstructured":"Li X, Bi X. Integrated Control of Fatty Acid Metabolism in Heart Failure. Metabolites. 2023;13(5). https:\/\/doi.org\/10.3390\/metabo13050615.","DOI":"10.3390\/metabo13050615"},{"key":"599_CR181","doi-asserted-by":"publisher","unstructured":"Yamamoto T, Sano M. Deranged Myocardial Fatty Acid Metabolism in Heart Failure. Int J Mol Sci. 2022;23(2). https:\/\/doi.org\/10.3390\/ijms23020996.","DOI":"10.3390\/ijms23020996"},{"issue":"23","key":"599_CR182","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1161\/circulationaha.111.060889","volume":"125","author":"A Chokshi","year":"2012","unstructured":"Chokshi A, Drosatos K, Cheema FH, Ji R, Khawaja T, Yu S, et al. Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure. Circulation. 2012;125(23):2844\u201353. https:\/\/doi.org\/10.1161\/circulationaha.111.060889.","journal-title":"Circulation"},{"issue":"15","key":"599_CR183","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1161\/circulationaha.106.668665","volume":"115","author":"N Sorokina","year":"2007","unstructured":"Sorokina N, O\u2019Donnell JM, McKinney RD, Pound KM, Woldegiorgis G, LaNoue KF, et al. Recruitment of Compensatory Pathways to Sustain Oxidative Flux With Reduced Carnitine Palmitoyltransferase I Activity Characterizes Inefficiency in Energy Metabolism in Hypertrophied Hearts. Circulation. 2007;115(15):2033\u201341. https:\/\/doi.org\/10.1161\/circulationaha.106.668665.","journal-title":"Circulation"},{"issue":"3","key":"599_CR184","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/circulationaha.123.066542","volume":"149","author":"W Xu","year":"2024","unstructured":"Xu W, Billon C, Li H, Wilderman A, Qi L, Graves A, et al. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation. 2024;149(3):227\u201350. https:\/\/doi.org\/10.1161\/circulationaha.123.066542.","journal-title":"Circulation"},{"issue":"21","key":"599_CR185","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1161\/circulationaha.116.026099","volume":"137","author":"N Diguet","year":"2018","unstructured":"Diguet N, Trammell SAJ, Tannous C, Deloux R, Piquereau J, Mougenot N, et al. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. Circulation. 2018;137(21):2256\u201373. https:\/\/doi.org\/10.1161\/circulationaha.116.026099.","journal-title":"Circulation"},{"issue":"12","key":"599_CR186","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/circulationaha.116.022495","volume":"134","author":"CF Lee","year":"2016","unstructured":"Lee CF, Chavez JD, Garcia-Menendez L, Choi Y, Roe ND, Chiao YA, et al. Normalization of NAD+ Redox Balance as a Therapy for Heart Failure. Circulation. 2016;134(12):883\u201394. https:\/\/doi.org\/10.1161\/circulationaha.116.022495.","journal-title":"Circulation"},{"key":"599_CR187","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23074022","author":"A Dimou","year":"2022","unstructured":"Dimou A, Tsimihodimos V, Bairaktari E. The critical role of the branched chain amino acids (BCAAs) catabolism-regulating enzymes, branched-chain aminotransferase (BCAT) and branched-chain \u03b1-keto acid dehydrogenase (BCKD), in human pathophysiology. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23074022.","journal-title":"Int J Mol Sci"},{"key":"599_CR188","doi-asserted-by":"publisher","unstructured":"Xiong Y, Jiang L, Li T. Aberrant branched-chain amino acid catabolism in cardiovascular diseases. Front Cardiovasc Med. 2022;9. https:\/\/doi.org\/10.3389\/fcvm.2022.965899.","DOI":"10.3389\/fcvm.2022.965899"},{"key":"599_CR189","doi-asserted-by":"publisher","unstructured":"Fine KS, Wilkins JT, Sawicki KT. Circulating Branched Chain Amino Acids and Cardiometabolic Disease. J Am Heart Assoc. 2024;13(7). https:\/\/doi.org\/10.1161\/jaha.123.031617.","DOI":"10.1161\/jaha.123.031617"},{"key":"599_CR190","doi-asserted-by":"publisher","unstructured":"Byrne NJ, Soni S, Takahara S, Ferdaoussi M, Al Batran R, Darwesh AM, et al. Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure. Circ Heart Fail. 2020;13(6). https:\/\/doi.org\/10.1161\/circheartfailure.119.006573.","DOI":"10.1161\/circheartfailure.119.006573"},{"key":"599_CR191","doi-asserted-by":"publisher","unstructured":"Goedeke L, Ma Y, Gaspar RC, Nasiri A, Lee J, Zhang D, et al. SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts. J Clin Invest. 2024;134(24). https:\/\/doi.org\/10.1172\/jci176708.","DOI":"10.1172\/jci176708"},{"key":"599_CR192","doi-asserted-by":"publisher","unstructured":"Ji R, Akashi H, Drosatos K, Liao X, Jiang H, Kennel PJ, et al. Increased de novo ceramide synthesis and accumulation in failing myocardium. JCI Insight. 2017;2(9). https:\/\/doi.org\/10.1172\/jci.insight.82922.","DOI":"10.1172\/jci.insight.82922"},{"key":"599_CR193","doi-asserted-by":"publisher","unstructured":"Kim Y, Lim JH, Kim EN, Hong YA, Park H-J, Chung S, et al. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice. Cell Death Dis. 2022;13(3). https:\/\/doi.org\/10.1038\/s41419-022-04726-8.","DOI":"10.1038\/s41419-022-04726-8"},{"key":"599_CR194","doi-asserted-by":"publisher","unstructured":"Wang X, Zhu L, Liu J, Ma Y, Qiu C, Liu C, et al. Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/s41467-024-45582-8.","DOI":"10.1038\/s41467-024-45582-8"},{"key":"599_CR195","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.046464","author":"L Edgar","year":"2021","unstructured":"Edgar L, Akbar N, Braithwaite AT, Krausgruber T, Gallart-Ayala H, Bailey J. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis. Circulation. 2021. https:\/\/doi.org\/10.1161\/circulationaha.120.046464.","journal-title":"Circulation"},{"key":"599_CR196","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac102","author":"A Devesa","year":"2022","unstructured":"Devesa A, Lobo-Gonzalez M, Martinez-Milla J, Oliva B, Garcia-Lunar I, Mastrangelo A. Bone marrow activation in response to metabolic syndrome and early atherosclerosis. Eur Heart J. 2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehac102.","journal-title":"Eur Heart J"},{"key":"599_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0590-4","author":"DM Fernandez","year":"2019","unstructured":"Fernandez DM, Rahman AH, Fernandez NF. Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019. https:\/\/doi.org\/10.1038\/s41591-019-0590-4.","journal-title":"Nat Med"},{"key":"599_CR198","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316770","author":"MAC Depuydt","year":"2020","unstructured":"Depuydt MAC, Prange KHM, Slenders L. Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics. Circ Res. 2020. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316770.","journal-title":"Circ Res"},{"key":"599_CR199","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0512-5","author":"RC Wirka","year":"2019","unstructured":"Wirka RC, Wagh D, Paik DT. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med. 2019. https:\/\/doi.org\/10.1038\/s41591-019-0512-5.","journal-title":"Nat Med"},{"key":"599_CR200","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.048378","author":"H Pan","year":"2020","unstructured":"Pan H, Xue C, Auerbach BJ. Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.048378.","journal-title":"Circulation"},{"issue":"5","key":"599_CR201","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell. 2020;180(5):862-877.e822. https:\/\/doi.org\/10.1016\/j.cell.2020.02.016.","journal-title":"Cell"},{"issue":"2","key":"599_CR202","doi-asserted-by":"publisher","first-page":"C617","DOI":"10.1152\/ajpcell.00218.2022","volume":"323","author":"L Li","year":"2022","unstructured":"Li L, Wang M, Ma Q, Ye J, Sun G. Role of glycolysis in the development of atherosclerosis. Am J Physiol Cell Physiol. 2022;323(2):C617\u201329. https:\/\/doi.org\/10.1152\/ajpcell.00218.2022.","journal-title":"Am J Physiol Cell Physiol"},{"key":"599_CR203","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.121.316721","author":"P Perrotta","year":"2022","unstructured":"Perrotta P, Van der Veken B, Van Der Veken P, Pintelon I, Roosens L, Adriaenssens E. PFKFB3 gene deletion in endothelial cells inhibits intraplaque angiogenesis and lesion formation in a murine model of atherosclerosis. Arterioscler Thromb Vasc Biol. 2022. https:\/\/doi.org\/10.1161\/atvbaha.121.316721.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"599_CR204","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.122.317764","author":"S Guo","year":"2022","unstructured":"Guo S. Gene-dosage effect of Pfkfb3 on monocyte\/macrophage biology and atherosclerosis. Arterioscler Thromb Vasc Biol. 2022. https:\/\/doi.org\/10.1161\/atvbaha.122.317764.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"599_CR205","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvad168","author":"T Cui","year":"2024","unstructured":"Cui T. Inhibition of PFKFB3 expression stimulates macrophage-derived VEGF-C and lymphangiogenesis in atherosclerosis. Cardiovasc Res. 2024. https:\/\/doi.org\/10.1093\/cvr\/cvad168.","journal-title":"Cardiovasc Res"},{"key":"599_CR206","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.116.307830","author":"A Aarup","year":"2016","unstructured":"Aarup A, Pedersen TX, Junker N, Christoffersen C, Bartels ED, Madsen M. Hypoxia-inducible factor-1 expression in macrophages promotes development of atherosclerosis. Arterioscler Thromb Vasc Biol. 2016. https:\/\/doi.org\/10.1161\/atvbaha.116.307830.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"599_CR207","doi-asserted-by":"publisher","unstructured":"Lee LY-H, Oldham WM, He H, Wang R, Mulhern R, Handy DE, et al. Interferon-\u03b3 Impairs Human Coronary Artery Endothelial Glucose Metabolism by Tryptophan Catabolism and Activates Fatty Acid Oxidation. Circulation. 2021;144(20):1612\u20131628. https:\/\/doi.org\/10.1161\/circulationaha.121.053960.","DOI":"10.1161\/circulationaha.121.053960"},{"key":"599_CR208","doi-asserted-by":"publisher","unstructured":"Xu X, Xu X-D, Ma M-Q, Liang Y, Cai Y-B, Zhu Z-X, et al. The mechanisms of ferroptosis and its role in atherosclerosis. Biomed Pharmacother. 2024;171. https:\/\/doi.org\/10.1016\/j.biopha.2023.116112.","DOI":"10.1016\/j.biopha.2023.116112"},{"key":"599_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04817-8","author":"M Chaffin","year":"2022","unstructured":"Chaffin M, Papangeli I, Simonson B. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04817-8.","journal-title":"Nature"},{"key":"599_CR210","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo1984","author":"D Reichart","year":"2022","unstructured":"Reichart D, Lindberg EL, Maatz H. Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. Science. 2022. https:\/\/doi.org\/10.1126\/science.abo1984.","journal-title":"Science"},{"key":"599_CR211","doi-asserted-by":"publisher","unstructured":"Wang C, Qiao S, Zhao Y, Tian H, Yan W, Hou X, et al. The KLF7\/PFKL\/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice. Nat Commun. 2023;14(1). https:\/\/doi.org\/10.1038\/s41467-023-36712-9.","DOI":"10.1038\/s41467-023-36712-9"},{"key":"599_CR212","doi-asserted-by":"publisher","unstructured":"Tran DH, Wang ZV. Glucose Metabolism in Cardiac Hypertrophy and Heart Failure. J Am Heart Assoc. 2019;8(12). https:\/\/doi.org\/10.1161\/jaha.119.012673.","DOI":"10.1161\/jaha.119.012673"},{"key":"599_CR213","doi-asserted-by":"publisher","unstructured":"Zhao M, Wei H, Li C, Zhan R, Liu C, Gao J, et al. Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy. Nat Commun. 2022;13(1). https:\/\/doi.org\/10.1038\/s41467-022-29060-7.","DOI":"10.1038\/s41467-022-29060-7"},{"key":"599_CR214","doi-asserted-by":"publisher","unstructured":"Greenwell AA, Gopal K, Ussher JR. Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy. Front Physiol. 2020;11. https:\/\/doi.org\/10.3389\/fphys.2020.570421.","DOI":"10.3389\/fphys.2020.570421"},{"issue":"11","key":"599_CR215","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.cmet.2022.09.008","volume":"34","author":"D Murashige","year":"2022","unstructured":"Murashige D, Jung JW, Neinast MD, Levin MG, Chu Q, Lambert JP, et al. Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure. Cell Metab. 2022;34(11):1749-1764.e1747. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.008.","journal-title":"Cell Metab"},{"key":"599_CR216","doi-asserted-by":"publisher","unstructured":"Tanase DM, Valasciuc E, Costea CF, Scripcariu DV, Ouatu A, Hurjui LL, et al. Duality of Branched-Chain Amino Acids in Chronic Cardiovascular Disease: Potential Biomarkers versus Active Pathophysiological Promoters. Nutrients. 2024;16(12). https:\/\/doi.org\/10.3390\/nu16121972.","DOI":"10.3390\/nu16121972"},{"key":"599_CR217","doi-asserted-by":"publisher","unstructured":"Gao C, Wang Y. YAP: The nexus between metabolism and cardiac remodeling. J Clin Invest. 2022;132(6). https:\/\/doi.org\/10.1172\/jci157664.","DOI":"10.1172\/jci157664"},{"issue":"3","key":"599_CR218","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/circresaha.120.316958","volume":"127","author":"AA Gibb","year":"2020","unstructured":"Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and Fibrosis. Circ Res. 2020;127(3):427\u201347. https:\/\/doi.org\/10.1161\/circresaha.120.316958.","journal-title":"Circ Res"},{"key":"599_CR219","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010051","author":"WP Lafuse","year":"2020","unstructured":"Lafuse WP, Wozniak DJ, Rajaram MVS. Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair. Cells. 2020. https:\/\/doi.org\/10.3390\/cells10010051.","journal-title":"Cells"},{"key":"599_CR220","doi-asserted-by":"publisher","unstructured":"Gaar-Humphreys KR, van den Brink A, Wekking M, Asselbergs FW, van Steenbeek FG, Harakalova M, et al. Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies. Front Cardiovasc Med. 2023;10. https:\/\/doi.org\/10.3389\/fcvm.2023.1114459.","DOI":"10.3389\/fcvm.2023.1114459"},{"key":"599_CR221","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"H-H Hu","year":"2018","unstructured":"Hu H-H, Chen D-Q, Wang Y-N, Feng Y-L, Cao G, Vaziri ND, et al. New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76\u201383. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.008.","journal-title":"Chem Biol Interact"},{"issue":"22","key":"599_CR222","doi-asserted-by":"publisher","first-page":"10711","DOI":"10.1111\/jcmm.17007","volume":"25","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zheng C, Gao Z, Wang L, Chen C, Zheng Y, et al. PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-\u03b2\/Smad2\/3 and Jak2\/Stat3 pathways through oxidative stress. J Cell Mol Med. 2021;25(22):10711\u201323. https:\/\/doi.org\/10.1111\/jcmm.17007.","journal-title":"J Cell Mol Med"},{"key":"599_CR223","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-020-0781-7","author":"S Liu","year":"2020","unstructured":"Liu S, Chen J, Shi J, Zhou W, Wang L, Fang W. M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment. Basic Res Cardiol. 2020. https:\/\/doi.org\/10.1007\/s00395-020-0781-7.","journal-title":"Basic Res Cardiol"},{"key":"599_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.09.001","author":"C Wang","year":"2017","unstructured":"Wang C, Zhang C, Liu L, Xi A, Chen B, Li Y. Macrophage-derived miR-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury. Mol Ther. 2017. https:\/\/doi.org\/10.1016\/j.ymthe.2016.09.001.","journal-title":"Mol Ther"},{"key":"599_CR225","doi-asserted-by":"publisher","unstructured":"Cordts K, Seelig D, Lund N, Carrier L, B\u00f6ger RH, Avanesov M, et al. Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy. Biomolecules. 2019;9(7). https:\/\/doi.org\/10.3390\/biom9070277.","DOI":"10.3390\/biom9070277"},{"key":"599_CR226","doi-asserted-by":"publisher","unstructured":"Bull\u00f3 M, Papandreou C, Garc\u00eda-Gavil\u00e1n J, Ruiz-Canela M, Li J, Guasch-Ferr\u00e9 M, et al. Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure. Metabolism. 2021;125. https:\/\/doi.org\/10.1016\/j.metabol.2021.154915.","DOI":"10.1016\/j.metabol.2021.154915"},{"issue":"4","key":"599_CR227","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/hjh.0000000000003075","volume":"40","author":"F Teng","year":"2022","unstructured":"Teng F, Han X, Yu P, Li P-B, Li H-H, Zhang Y-L. Time series proteome profile analysis reveals a protective role of citrate synthase in angiotensin II-induced atrial fibrillation. J Hypertens. 2022;40(4):765\u201375. https:\/\/doi.org\/10.1097\/hjh.0000000000003075.","journal-title":"J Hypertens"},{"issue":"20","key":"599_CR228","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/circulationaha.118.035202","volume":"138","author":"C Yao","year":"2018","unstructured":"Yao C, Veleva T, Scott L, Cao S, Li L, Chen G, et al. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation. 2018;138(20):2227\u201342. https:\/\/doi.org\/10.1161\/circulationaha.118.035202.","journal-title":"Circulation"},{"issue":"6654","key":"599_CR229","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.abq3061","volume":"381","author":"M Hulsmans","year":"2023","unstructured":"Hulsmans M, Schloss MJ, Lee IH, Bapat A, Iwamoto Y, Vinegoni C, et al. Recruited macrophages elicit atrial fibrillation. Science. 2023;381(6654):231\u20139. https:\/\/doi.org\/10.1126\/science.abq3061.","journal-title":"Science"},{"issue":"1","key":"599_CR230","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/circulationaha.119.043581","volume":"142","author":"Y Xu","year":"2020","unstructured":"Xu Y, Jiang H, Li L, Chen F, Liu Y, Zhou M, et al. Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets. Circulation. 2020;142(1):49\u201364. https:\/\/doi.org\/10.1161\/circulationaha.119.043581.","journal-title":"Circulation"},{"issue":"11","key":"599_CR231","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1016\/j.jtha.2023.06.039","volume":"21","author":"H Jiang","year":"2023","unstructured":"Jiang H, Zhang L, Yang M, Li G, Ding C, Xin M, et al. Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling. J Thromb Haemost. 2023;21(11):3224\u201335. https:\/\/doi.org\/10.1016\/j.jtha.2023.06.039.","journal-title":"J Thromb Haemost"},{"key":"599_CR232","doi-asserted-by":"publisher","unstructured":"Tan M, Yin Y, Ma X, Zhang J, Pan W, Tan M, et al. Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis. Cell Death Dis. 2023;14(2). https:\/\/doi.org\/10.1038\/s41419-023-05645-y.","DOI":"10.1038\/s41419-023-05645-y"},{"issue":"11","key":"599_CR233","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/jn\/nxaa273","volume":"150","author":"C Papandreou","year":"2020","unstructured":"Papandreou C, Hern\u00e1ndez-Alonso P, Bull\u00f3 M, Ruiz-Canela M, Li J, Guasch-Ferr\u00e9 M, et al. High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevenci\u00f3n con Dieta Mediterr\u00e1nea (PREDIMED) Study. J Nutr. 2020;150(11):2882\u20139. https:\/\/doi.org\/10.1093\/jn\/nxaa273.","journal-title":"J Nutr"},{"issue":"4","key":"599_CR234","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2018.03.055","volume":"173","author":"C Jang","year":"2018","unstructured":"Jang C, Chen L, Rabinowitz JD. Metabolomics and Isotope Tracing. Cell. 2018;173(4):822\u201337. https:\/\/doi.org\/10.1016\/j.cell.2018.03.055.","journal-title":"Cell"},{"key":"599_CR235","doi-asserted-by":"publisher","DOI":"10.1039\/c6fo00477f","author":"N Martinez-Micaelo","year":"2016","unstructured":"Martinez-Micaelo N, Gonzalez-Abuin N, Pinent M, Ardevol A, Blay M. Dietary fatty acid composition is sensed by the NLRP3 inflammasome: omega-3 fatty acid DHA prevents NLRP3 activation in human macrophages. Food Funct. 2016. https:\/\/doi.org\/10.1039\/c6fo00477f.","journal-title":"Food Funct"},{"key":"599_CR236","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.m075879","author":"LL Shen","year":"2017","unstructured":"Shen LL, Yang Y, Ou TT, Key CCC, Tong SH, Sequeira RC. Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy. J Lipid Res. 2017. https:\/\/doi.org\/10.1194\/jlr.m075879.","journal-title":"J Lipid Res"},{"key":"599_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108756","author":"M Bambouskova","year":"2021","unstructured":"Bambouskova M, Potuckova L, Paulenda T, Kerndl M, Mogilenko DA, Lizotte K. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 2021. https:\/\/doi.org\/10.1016\/j.celrep.2021.108756.","journal-title":"Cell Rep"},{"key":"599_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395786","author":"BJ Xu","year":"2024","unstructured":"Xu BJ, Liu Y, Li N, Geng Q. Lactate and lactylation in macrophage metabolic reprogramming: current progress and outstanding issues. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1395786.","journal-title":"Front Immunol"},{"key":"599_CR239","doi-asserted-by":"publisher","DOI":"10.3791\/53424","author":"J Van den Bossche","year":"2015","unstructured":"Van den Bossche J, Baardman J, de Winther MPJ. Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis. J Vis Exp. 2015. https:\/\/doi.org\/10.3791\/53424.","journal-title":"J Vis Exp"},{"key":"599_CR240","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00096.2016","author":"GE Gonzalez","year":"2016","unstructured":"Gonzalez GE, Rhaleb NE, D\u2019Ambrosio MA, Nakagawa P, Liao TD, Peterson EL. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol. 2016. https:\/\/doi.org\/10.1152\/ajpheart.00096.2016.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"599_CR241","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.203","author":"F Edelmann","year":"2015","unstructured":"Edelmann F, Holzendorf V, Wachter R, Nolte K, Schmidt AG, Kraigher-Krainer E. Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial. Eur J Heart Fail. 2015. https:\/\/doi.org\/10.1002\/ejhf.203.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"599_CR242","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"issue":"8","key":"599_CR243","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, et al. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med. 2019;380(8):752\u201362. https:\/\/doi.org\/10.1056\/NEJMoa1809798.","journal-title":"N Engl J Med"},{"issue":"26","key":"599_CR244","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"J-C Tardif","year":"2019","unstructured":"Tardif J-C, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"issue":"16","key":"599_CR245","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"D Anker Stefan","year":"2021","unstructured":"Anker Stefan D, Butler J, Filippatos G, Ferreira Jo\u00e3o P, Bocchi E, B\u00f6hm M, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2107038.","journal-title":"N Engl J Med"},{"issue":"21","key":"599_CR246","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JV McMurray John","year":"2019","unstructured":"McMurray John JV, Solomon Scott D, Inzucchi Silvio E, K\u00f8ber L, Kosiborod Mikhail N, Martinez Felipe A, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303.","journal-title":"N Engl J Med"},{"issue":"15","key":"599_CR247","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker Stefan D, Butler J, Filippatos G, Pocock Stuart J, Carson P, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413\u201324. https:\/\/doi.org\/10.1056\/NEJMoa2022190.","journal-title":"N Engl J Med"},{"issue":"12","key":"599_CR248","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"D Solomon Scott","year":"2022","unstructured":"Solomon Scott D, McMurray John JV, Claggett B, de Boer RA, DeMets D, Hernandez Adrian F, et al. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022;387(12):1089\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2206286.","journal-title":"N Engl J Med"},{"key":"599_CR249","doi-asserted-by":"publisher","unstructured":"Wiggers H. SGLT2 Inhibitors and Their Effect on Metabolism in Patients With Heart Failure. Circ Heart Fail. 2024;17(11). https:\/\/doi.org\/10.1161\/circheartfailure.124.012373.","DOI":"10.1161\/circheartfailure.124.012373"},{"issue":"11","key":"599_CR250","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/circulationaha.122.060402","volume":"146","author":"S Selvaraj","year":"2022","unstructured":"Selvaraj S, Fu Z, Jones P, Kwee LC, Windsor SL, Ilkayeva O, et al. Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation. 2022;146(11):808\u201318. https:\/\/doi.org\/10.1161\/circulationaha.122.060402.","journal-title":"Circulation"},{"key":"599_CR251","doi-asserted-by":"publisher","unstructured":"Selvaraj S, Patel S, Sauer AJ, McGarrah RW, Jones P, Kwee LC, et al. Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction. Circ Heart Fail. 2024;17(11). https:\/\/doi.org\/10.1161\/circheartfailure.124.011980.","DOI":"10.1161\/circheartfailure.124.011980"},{"issue":"10","key":"599_CR252","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1161\/circulationaha.123.065134","volume":"148","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Reddy YNV, Braun A, Sorimachi H, Omar M, Popovic D, et al. Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial. Circulation. 2023;148(10):834\u201344. https:\/\/doi.org\/10.1161\/circulationaha.123.065134.","journal-title":"Circulation"},{"issue":"7","key":"599_CR253","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.cardfail.2025.01.028","volume":"31","author":"N Kodur","year":"2025","unstructured":"Kodur N, Nguyen C, Tang WHW. Therapeutic Ketosis for Heart Failure: A State-of-the-Art Review. J Card Fail. 2025;31(7):1051\u201361. https:\/\/doi.org\/10.1016\/j.cardfail.2025.01.028.","journal-title":"J Card Fail"},{"key":"599_CR254","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.008","author":"CG Santos-Gallego","year":"2021","unstructured":"Santos-Gallego CG, Vargas-Delgado AP, Requena-Ibanez JA. Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.008.","journal-title":"J Am Coll Cardiol"},{"key":"599_CR255","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2021.04.014","author":"JA Requena-Ibanez","year":"2021","unstructured":"Requena-Ibanez JA, Santos-Gallego CG, Rodriguez-Cordero A. Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study. JACC Heart Fail. 2021. https:\/\/doi.org\/10.1016\/j.jchf.2021.04.014.","journal-title":"JACC Heart Fail"},{"key":"599_CR256","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.036459","author":"R Nielsen","year":"2019","unstructured":"Nielsen R, Moller N, Gormsen LC. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation. 2019. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036459.","journal-title":"Circulation"},{"issue":"24","key":"599_CR257","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2307563.","journal-title":"N Engl J Med"},{"issue":"12","key":"599_CR258","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"N Kosiborod Mikhail","year":"2023","unstructured":"Kosiborod Mikhail N, Abildstr\u00f8m Steen Z, Borlaug Barry A, Butler J, Rasmussen S, Davies M, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389(12):1069\u201384. https:\/\/doi.org\/10.1056\/NEJMoa2306963.","journal-title":"N Engl J Med"},{"issue":"15","key":"599_CR259","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","volume":"390","author":"N Kosiborod Mikhail","year":"2024","unstructured":"Kosiborod Mikhail N, Petrie Mark C, Borlaug Barry A, Butler J, Davies Melanie J, Hovingh GK, et al. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. N Engl J Med. 2024;390(15):1394\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa2313917.","journal-title":"N Engl J Med"},{"issue":"10437","key":"599_CR260","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/s0140-6736(24)00469-0","volume":"403","author":"J Butler","year":"2024","unstructured":"Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstr\u00f8m SZ, Davies MJ, et al. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet. 2024;403(10437):1635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(24)00469-0.","journal-title":"Lancet"},{"issue":"17","key":"599_CR261","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jacc.2024.08.028","volume":"84","author":"S Verma","year":"2024","unstructured":"Verma S, Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, et al. Inflammation in Obesity-Related HFpEF. J Am Coll Cardiol. 2024;84(17):1646\u201362. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.028.","journal-title":"J Am Coll Cardiol"},{"key":"599_CR262","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Vega D, S\u00e1nchez-L\u00f3pez D, Rodr\u00edguez-Carnero G, Villar-Taibo R, Vi\u00f1uela JE, Lesteg\u00e1s-Soto A, et al. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network. Cardiovasc Diabetol. 2024;23(1). https:\/\/doi.org\/10.1186\/s12933-023-02096-9.","DOI":"10.1186\/s12933-023-02096-9"},{"key":"599_CR263","doi-asserted-by":"publisher","unstructured":"Aday AW, Ridker PM. Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond. Front Cardiovasc Med. 2018;5. https:\/\/doi.org\/10.3389\/fcvm.2018.00062.","DOI":"10.3389\/fcvm.2018.00062"},{"issue":"8","key":"599_CR264","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/ehjcvp\/pvaf058","volume":"11","author":"S Finocchiaro","year":"2025","unstructured":"Finocchiaro S, Mazzone PM, Ammirabile N, Bordonaro C, Cusmano C, Cutore L, et al. Anti-inflammatory pharmacotherapy in patients with cardiovascular disease. Eur Heart J Cardiovasc Pharmacother. 2025;11(8):712\u201328. https:\/\/doi.org\/10.1093\/ehjcvp\/pvaf058.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"4","key":"599_CR265","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jjcc.2023.05.006","volume":"82","author":"Y Wada","year":"2023","unstructured":"Wada Y, Jensen C, Meyer ASP, Zonoozi AAM, Honda H. Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial. J Cardiol. 2023;82(4):279\u201385. https:\/\/doi.org\/10.1016\/j.jjcc.2023.05.006.","journal-title":"J Cardiol"},{"key":"599_CR266","doi-asserted-by":"publisher","unstructured":"Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, et al. Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial. EBioMedicine. 2022;80. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104013.","DOI":"10.1016\/j.ebiom.2022.104013"},{"key":"599_CR267","doi-asserted-by":"publisher","unstructured":"Grillo TG, Silveira Caroline Ferreira dSMP, Quaglio AEV, Dutra RdM, Baima JP, Bazan SGZ, et al. Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature. World J Cardiol. 2023;15(5):217\u2013228. https:\/\/doi.org\/10.4330\/wjc.v15.i5.217.","DOI":"10.4330\/wjc.v15.i5.217"},{"key":"599_CR268","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00520-1","author":"PM Ridker","year":"2021","unstructured":"Ridker PM, Devalaraja M, Baeres FMM. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021. https:\/\/doi.org\/10.1016\/S0140-6736(21)00520-1.","journal-title":"Lancet"},{"key":"599_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.049","author":"K Broch","year":"2021","unstructured":"Broch K, Anstensrud AK, Woxholt S. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2021. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.049.","journal-title":"J Am Coll Cardiol"},{"key":"599_CR270","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038010","author":"BM Everett","year":"2019","unstructured":"Everett BM, Cornel JH, Lainscak M. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 2019. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038010.","journal-title":"Circulation"},{"key":"599_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32814-3","author":"PM Ridker","year":"2018","unstructured":"Ridker PM, MacFadyen JG, Everett BM. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet. 2018. https:\/\/doi.org\/10.1016\/S0140-6736(17)32814-3.","journal-title":"Lancet"},{"issue":"19","key":"599_CR272","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"M Nidorf Stefan","year":"2020","unstructured":"Nidorf Stefan M, Fiolet Aernoud TL, Mosterd A, Eikelboom John W, Schut A, Opstal Tjerk SJ, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"issue":"26","key":"599_CR273","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","volume":"46","author":"M Samuel","year":"2025","unstructured":"Samuel M, Berry C, Dub\u00e9 M-P, Koenig W, L\u00f3pez-Send\u00f3n J, Maggioni AP, et al. Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis. Eur Heart J. 2025;46(26):2552\u201363. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf174.","journal-title":"Eur Heart J"},{"issue":"1","key":"599_CR274","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40256-025-00743-y","volume":"26","author":"H-Y Li","year":"2025","unstructured":"Li H-Y, Cheriyan J, Chan T-K, Yiu K-H, Tse H-F, Wilkinson IB, et al. Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide. Am J Cardiovasc Drugs. 2025;26(1):107\u201320. https:\/\/doi.org\/10.1007\/s40256-025-00743-y.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"599_CR275","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa2405922","volume":"392","author":"S Jolly Sanjit","year":"2025","unstructured":"Jolly Sanjit S, d\u2019Entremont M-A, Lee Shun F, Mian R, Tyrwhitt J, Kedev S, et al. Colchicine in Acute Myocardial Infarction. N Engl J Med. 2025;392(7):633\u201342. https:\/\/doi.org\/10.1056\/NEJMoa2405922.","journal-title":"N Engl J Med"},{"key":"599_CR276","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.027","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013. https:\/\/doi.org\/10.1016\/j.jacc.2012.10.027.","journal-title":"J Am Coll Cardiol"},{"key":"599_CR277","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050771","author":"DC Tong","year":"2020","unstructured":"Tong DC, Quinn S, Nasis A. Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial. Circulation. 2020. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050771.","journal-title":"Circulation"},{"key":"599_CR278","doi-asserted-by":"publisher","unstructured":"Ding P, Song Y, Yang Y, Zeng C. NLRP3 inflammasome and pyroptosis in cardiovascular diseases and exercise intervention. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1368835.","DOI":"10.3389\/fphar.2024.1368835"},{"issue":"1","key":"599_CR279","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/fjc.0000000000000931","volume":"77","author":"GF Wohlford","year":"2020","unstructured":"Wohlford GF, Van Tassell BW, Billingsley HE, Kadariya D, Canada JM, Carbone S, et al. Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure. J Cardiovasc Pharmacol. 2020;77(1):49\u201360. https:\/\/doi.org\/10.1097\/fjc.0000000000000931.","journal-title":"J Cardiovasc Pharmacol"},{"key":"599_CR280","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000000247","author":"C Marchetti","year":"2015","unstructured":"Marchetti C, Toldo S, Chojnacki J, Mezzaroma E, Liu K, Salloum FN. Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse. J Cardiovasc Pharmacol. 2015. https:\/\/doi.org\/10.1097\/fjc.0000000000000247.","journal-title":"J Cardiovasc Pharmacol"},{"key":"599_CR281","doi-asserted-by":"publisher","unstructured":"Nassiri S, Van de Bovenkamp AA, Remmelzwaal S, Sorea O, de Man F, Handoko ML. Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis. Open Heart. 2024;11(1). https:\/\/doi.org\/10.1136\/openhrt-2023-002579.","DOI":"10.1136\/openhrt-2023-002579"},{"key":"599_CR282","doi-asserted-by":"publisher","unstructured":"van de Bovenkamp AA, Geurkink KTJ, Oosterveer FTP, Man FSd, Kok WEM, Bronzwaer PNA, et al. Trimetazidine in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Cross-Over Trial. ESC Heart Fail. 2023;10(5):2998\u20133010. https:\/\/doi.org\/10.1002\/ehf2.14418.","DOI":"10.1002\/ehf2.14418"},{"key":"599_CR283","doi-asserted-by":"publisher","unstructured":"Locasale J, Yao C-H, Liu G-Y, Wang R, Moon SH, Gross RW, et al. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of \u03b2-oxidation. PLoS Biol. 2018;16(3). https:\/\/doi.org\/10.1371\/journal.pbio.2003782.","DOI":"10.1371\/journal.pbio.2003782"},{"issue":"3","key":"599_CR284","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmet.2018.06.001","volume":"28","author":"AS Divakaruni","year":"2018","unstructured":"Divakaruni AS, Hsieh WY, Minarrieta L, Duong TN, Kim KKO, Desousa BR, et al. Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. Cell Metab. 2018;28(3):490-503.e497. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.001.","journal-title":"Cell Metab"},{"issue":"1","key":"599_CR285","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1812792.","journal-title":"N Engl J Med"},{"key":"599_CR286","doi-asserted-by":"publisher","unstructured":"Nicholls SJ, Lincoff AM, Garcia M, Bash D, Ballantyne CM, Barter PJ, et al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk. JAMA. 2020;324(22). https:\/\/doi.org\/10.1001\/jama.2020.22258.","DOI":"10.1001\/jama.2020.22258"},{"key":"599_CR287","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa652","author":"MJ Budoff","year":"2020","unstructured":"Budoff MJ, Bhatt DL, Kinninger A. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa652.","journal-title":"Eur Heart J"},{"issue":"21","key":"599_CR288","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/circulationaha.115.020226","volume":"133","author":"H Sun","year":"2016","unstructured":"Sun H, Olson KC, Gao C, Prosdocimo DA, Zhou M, Wang Z, et al. Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. Circulation. 2016;133(21):2038\u201349. https:\/\/doi.org\/10.1161\/circulationaha.115.020226.","journal-title":"Circulation"},{"key":"599_CR289","doi-asserted-by":"publisher","unstructured":"Rom O, Liu Y, Finney AC, Ghrayeb A, Zhao Y, Shukha Y, et al. Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis. Redox Biol. 2022;52. https:\/\/doi.org\/10.1016\/j.redox.2022.102313.","DOI":"10.1016\/j.redox.2022.102313"},{"key":"599_CR290","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97441-x","author":"TS Postler","year":"2021","unstructured":"Postler TS, Peng V, Bhatt DM, Ghosh S. Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-97441-x.","journal-title":"Sci Rep"},{"issue":"5","key":"599_CR291","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/cvr\/cvaa171","volume":"117","author":"A Seneviratne","year":"2021","unstructured":"Seneviratne A, Cave L, Hyde G, Moestrup SK, Carling D, Mason JC, et al. Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase. Cardiovasc Res. 2021;117(5):1295\u2013308. https:\/\/doi.org\/10.1093\/cvr\/cvaa171.","journal-title":"Cardiovasc Res"},{"key":"599_CR292","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70152-9","author":"D Preiss","year":"2014","unstructured":"Preiss D, Lloyd SM, Ford I. Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol. 2014. https:\/\/doi.org\/10.1016\/S2213-8587(13)70152-9.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"599_CR293","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz203","author":"M Mohan","year":"2019","unstructured":"Mohan M, Al-Talabany S, McKinnie A. A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. Eur Heart J. 2019. https:\/\/doi.org\/10.1093\/eurheartj\/ehz203.","journal-title":"Eur Heart J"},{"issue":"42","key":"599_CR294","doi-asserted-by":"publisher","first-page":"2002131","DOI":"10.1002\/adfm.202002131","volume":"30","author":"C Li","year":"2020","unstructured":"Li C, Dou Y, Chen Y, Qi Y, Li L, Han S, et al. Site-specific microRNA-33 antagonism by pH-responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity. Adv Funct Mater. 2020;30(42):2002131. https:\/\/doi.org\/10.1002\/adfm.202002131.","journal-title":"Adv Funct Mater"},{"issue":"5","key":"599_CR295","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/s0735-1097(01)01591-1","volume":"38","author":"MW Hwang","year":"2001","unstructured":"Hwang MW, Matsumori A, Furukawa Y, Ono K, Okada M, Iwasaki A, et al. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol. 2001;38(5):1546\u201353. https:\/\/doi.org\/10.1016\/s0735-1097(01)01591-1.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"599_CR296","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","volume":"173","author":"M Bujak","year":"2008","unstructured":"Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, et al. Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol. 2008;173(1):57\u201367. https:\/\/doi.org\/10.2353\/ajpath.2008.070974.","journal-title":"Am J Pathol"},{"key":"599_CR297","doi-asserted-by":"publisher","unstructured":"Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9(1). https:\/\/doi.org\/10.1038\/s41392-024-01840-1.","DOI":"10.1038\/s41392-024-01840-1"},{"issue":"12","key":"599_CR298","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/circresaha.124.325212","volume":"135","author":"J Wang","year":"2024","unstructured":"Wang J, Du H, Xie W, Bi J, Zhang H, Liu X, et al. CAR-macrophage therapy alleviates myocardial ischemia-reperfusion injury. Circ Res. 2024;135(12):1161\u201374. https:\/\/doi.org\/10.1161\/circresaha.124.325212.","journal-title":"Circ Res"},{"key":"599_CR299","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.065506","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhang Y, Duan X, Wang B, Zhan Z. Targeting NPM1 epigenetically promotes postinfarction cardiac repair by reprogramming reparative macrophage metabolism. Circulation. 2024. https:\/\/doi.org\/10.1161\/circulationaha.123.065506.","journal-title":"Circulation"},{"key":"599_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2021.05.008","author":"AJ Mouton","year":"2021","unstructured":"Mouton AJ, Flynn ER, Moak SP, Aitken NM, Omoto ACM, Li X. Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism. J Mol Cell Cardiol. 2021. https:\/\/doi.org\/10.1016\/j.yjmcc.2021.05.008.","journal-title":"J Mol Cell Cardiol"},{"key":"599_CR301","doi-asserted-by":"publisher","unstructured":"Arnold PK, Finley LWS. Regulation and function of the mammalian tricarboxylic acid\u00a0cycle. J Biol Chem. 2023;299(2). https:\/\/doi.org\/10.1016\/j.jbc.2022.102838.","DOI":"10.1016\/j.jbc.2022.102838"},{"issue":"1","key":"599_CR302","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","volume":"19","author":"SJG Knottnerus","year":"2018","unstructured":"Knottnerus SJG, Bleeker JC, W\u00fcst RCI, Ferdinandusse S, Ijlst L, Wijburg FA, et al. Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle. Rev Endocr Metab Disord. 2018;19(1):93\u2013106. https:\/\/doi.org\/10.1007\/s11154-018-9448-1.","journal-title":"Rev Endocr Metab Disord"},{"key":"599_CR303","doi-asserted-by":"publisher","unstructured":"Guerra IMS, Ferreira HB, Melo T, Rocha H, Moreira S, Diogo L, et al. Mitochondrial Fatty Acid \u03b2-Oxidation Disorders: From Disease to Lipidomic Studies\u2014A Critical Review. Int J Mol Sci. 2022;23(22). https:\/\/doi.org\/10.3390\/ijms232213933.","DOI":"10.3390\/ijms232213933"},{"key":"599_CR304","doi-asserted-by":"publisher","unstructured":"Kemp F, Braverman EL, Byersdorfer CA. Fatty acid oxidation in immune function. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1420336.","DOI":"10.3389\/fimmu.2024.1420336"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00599-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00599-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:04:45Z","timestamp":1790237085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00599-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":304,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00599-x","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"185"}}